Myocardial ischemia assessment method, microcirculation disturbance assessment method and calculation method

Direct calculation of CTP-FFR through CTP image processing solves the problem of complex and inaccurate central muscle ischemia evaluation methods in the prior art, achieves rapid and accurate ischemia evaluation, and simplifies the myocardial ischemia evaluation process.

CN118941552AActive Publication Date: 2024-11-12SHANGHAI JIAOTONG UNIV
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202411254056.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-06
Publication Date
2024-11-12
Estimated Expiration
2044-09-06

AI Technical Summary

Technical Problem

The existing myocardial ischemia evaluation method relies on fluid mechanics simulation, which has problems such as complex calculations, high cost, slow speed and inaccurate results. The data dependence of machine learning methods is poor, and the learning results are not good in the data that have never been seen.

Method used

Using imaging methods based on CTP image processing, CTP-FFR is directly calculated, and quantitative myocardial blood flow is obtained by mapping myocardial region to coronary artery vascular tree, and the proportion of myocardial ischemia caused by coronary stenosis is achieved to achieve a fast and accurate overall Quantitative evaluation of myocardial ischemia.

Benefits of technology

Without fluid mechanics simulation, the results are more accurate and faster, and can quickly and accurately evaluate the ischemia of actual myocardial perfusion and simplify the myocardial ischemia evaluation process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118941552A_ABST
    Figure CN118941552A_ABST
Patent Text Reader

Abstract

The invention discloses a myocardial ischemia assessment method. The method comprises the following steps: acquiring a first image (CCTA) and a second image (CTP); obtaining a mapping image according to the first image and the second image; calibrating a target blood vessel perfusion area in the mapping image; according to the second image and the target blood vessel perfusion area, the myocardial blood flow MBFhyper-stensis of the target blood vessel perfusion area under the narrow condition is obtained; the method comprises the following steps: acquiring a myocardial blood flow MBFhyper-normal under a simulated normal condition; according to the myocardial blood flow MBFhyper-stensis of the target blood vessel perfusion area under the narrow condition and the myocardial blood flow MBFhyper-normal of the target blood vessel perfusion area under the simulated normal condition, the proportion CTP-FFR of myocardial ischemia caused by coronary artery blood vessel stenosis is evaluated. By means of the method, rapid and accurate quantitative evaluation of overall myocardial ischemia can be achieved. The invention further discloses a myocardial ischemia evaluation system, a microcirculation disturbance evaluation method and system, a microcirculation disturbance resistance calculation method and system, electronic equipment and a computer readable storage medium.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical engineering technology, and in particular to a method and system for evaluating myocardial ischemia, a method and system for evaluating microcirculation disorders, and a method and system for calculating microcirculation disorders. Background Art

[0002] Myocardial ischemia refers to insufficient blood supply to the heart muscle, which results in myocardial cells not getting enough oxygen and nutrients, thus affecting the normal function of the heart. Myocardial ischemia is a serious cardiovascular disease. If not treated in time, it may lead to myocardial infarction and even life-threatening. Chronic coronary syndrome (CCS) refers to a series of symptoms and signs of myocardial ischemia caused by the continuous progression of coronary atherosclerosis, among which coronary artery lesions can be manifested as epicardial coronary artery stenosis and / or microvascular dysfunction.

[0003] The myocardial ischemia assessment method and system have non-therapeutic purposes. The myocardial ischemia assessment method and system are based on the processing of medical images, that is, their direct objects are medical images, such as CCTA and CTP.

[0004] Chinese invention patent CN117476238B, a computational fluid dynamics simulation analysis method and system for evaluating myocardial ischemia, discloses a method of computational fluid dynamics based on patient-specific images and protects a method of calculating the corresponding myocardial perfusion area of ​​blood vessels based on images.

[0005] The paper "A Novel CT Perfusion-Based Fractional Flow Reserve Algorithm for Detecting Coronary Artery Disease" published by Xuelian Gao et al. disclosed the use of CTP images to calculate MBF and then used fluid dynamics simulation methods to optimize the CT-FFR (blood flow reserve fraction based on coronary CT angiography) calculation.

[0006] For epicardial coronary artery stenosis, the existing non-invasive ischemia assessment methods are mostly based on the calculation of blood flow and pressure based on the principles of computational fluid dynamics, such as the blood flow reserve fraction (CT angiography derived-Fractional Flow Reserve, CT-FFR) technology based on coronary CT angiography. In the prior art, the simulation calculation of the proportion of myocardial ischemia caused by coronary artery stenosis using mechanical simulation CT-FFR often includes the following steps: Image acquisition: Acquire CT images of the heart and blood vessels; Image segmentation: Use image processing algorithms to segment tissues, blood vessels and blood in CT images, and identify the internal and external boundaries of blood vessels, as well as the wall layer of the heart; Fluid dynamics model establishment: Use the segmented image data and combine individual hemodynamic parameters to establish a three-dimensional model of the heart and blood vessels. Pressure gradient calculation: In the established fluid dynamics model, calculate the pressure gradient at the stenosis of the blood vessel. Pressure gradient refers to the pressure change from the proximal end to the distal end of the blood vessel when blood flows in the blood vessel; FFR calculation: In the absence of stenosis, the pressure gradient in the blood vessel is inversely proportional to the radius of the blood vessel. Therefore, the FFR value can be calculated by comparing the pressure gradient before and after stenosis. It can be seen that the existing method of calculating CT-FFR by fluid dynamics simulation is to obtain the pressure gradient in the blood vessel before and after stenosis after image processing of the acquired CT image, and calculate the blood flow reserve fraction FFR based on the pressure gradient in the blood vessel before and after stenosis.

[0007] The existing mainstream computing methods mainly include fluid mechanics simulation and machine learning methods. Fluid mechanics simulation requires specific boundary conditions as input, and also takes a lot of time and computing power. It is costly, slow, and there is uncertainty in the parameters of the input model, which affects the reliability of the simulation results. It requires professional software and technicians and is complex to operate. Although machine learning methods have fast calculation speeds, the large amount of data required for training models also comes from the results of mechanical simulation calculations, which is data-dependent. In addition, the training model usually performs well on the training data set, but may perform poorly on unseen data, affecting the reliability of the learning results.

[0008] Therefore, existing methods of fluid mechanics simulation and training models have problems such as complex calculations, high costs, slow speeds, inaccurate results, and unreliable results. Summary of the invention

[0009] The object of the present invention is to solve the above-mentioned problems.

[0010] The myocardial ischemia assessment method and system, microcirculation disorder assessment method and system, and microcirculation disorder calculation method and system provided by the present invention all have non-therapeutic purposes.

[0011] The myocardial ischemia assessment method and system, microcirculation disorder assessment method and system, and microcirculation disorder calculation method and system provided by the present invention are all based on the processing of medical images, that is, their direct objects are medical images, such as CCTA and CTP.

[0012] In the first aspect, compared with calculating CT-FFR through CT images, the present invention provides a non-invasive assessment method for myocardial ischemia based only on imaging, that is, the myocardial ischemia assessment method can obtain CTP-FFR directly based on the image processing of CTP, and CTP-FFR is based on the blood flow reserve fraction of CT myocardial perfusion images CTP under load state, so as to quantify the degree of ischemia caused by epicardial vascular stenosis. The myocardial ischemia assessment method provided by the present invention does not require the aid of fluid mechanics. Since mechanical simulation is a simulation calculation, the assessment of myocardial ischemia obtained according to mechanical simulation is a simulation result. Compared with the assessment of myocardial ischemia obtained according to mechanical simulation, the results obtained by the image processing-based quantification method of myocardial ischemia provided by the present invention are more accurate and faster. The present invention evaluates the ischemic condition of actual myocardial perfusion through CTP-FFR, and has the advantages of rapid and accurate quantitative assessment of overall myocardial ischemia.

[0013] The embodiment of the present invention discloses a method for evaluating myocardial ischemia, including: acquiring a first image and a second image, the first image being a coronary CT angiography image CCTA, and the second image being a CT myocardial perfusion image CTP under load; mapping a left ventricular myocardial region to each blood vessel in a coronary artery vascular tree by an image processing method according to the first image and the second image, to obtain a mapping image; calibrating a target vascular perfusion region in the mapping image; acquiring a time-attenuation curve of myocardial tissue in the myocardial perfusion region according to the second image, acquiring a quantitative myocardial blood flow in the target vascular perfusion region based on the time-attenuation curve of the myocardial tissue and the target vascular perfusion region, and using the quantitative myocardial blood flow in the target vascular perfusion region as the myocardial blood flow MBF of the target vascular perfusion region under stenosis. hyper-stenosis ; Obtain the quantitative myocardial blood flow of the normal perfusion area of ​​the target vessel, and use the quantitative myocardial blood flow of the normal perfusion area of ​​the target vessel as the myocardial blood flow MBF of the target vessel perfusion area under simulated normal conditions hyper-normal ; Based on the myocardial blood flow (MBF) of the target vascular perfusion area under stenosis hyper-stenosis MBF and target vascular perfusion area in simulated normal myocardial blood flow hyper - normal , CTP-FFR is used to evaluate the proportion of myocardial ischemia caused by coronary artery stenosis.

[0014] By adopting the above technical solution, the proportion of myocardial ischemia caused by coronary artery stenosis CTP-FFR is calculated by processing the first image and the second image and using the myocardial blood flow MBF obtained by the second image CTP. That is to say, the method for evaluating myocardial ischemia provided by the present invention is directly based on the image processing of CTP to obtain CTP-FFR, so as to quantify the degree of ischemia caused by epicardial vascular stenosis. Unlike CT-FFR, which is used to evaluate ischemia caused by epicardial vascular stenosis, CTP-FFR can more quickly, accurately and reliably quantitatively evaluate the ischemia of actual myocardial perfusion.

[0015] According to another specific embodiment of the present invention, a time-attenuation curve of myocardial tissue in a myocardial perfusion region is obtained based on the second image, and a quantitative myocardial blood flow in the target vascular perfusion region is obtained based on the time-attenuation curve of the myocardial tissue and the target vascular perfusion region, and the quantitative myocardial blood flow in the target vascular perfusion region is used as the myocardial blood flow MBF of the target vascular perfusion region in the case of stenosis. hyper-stenosis , including: obtaining the quantitative myocardial blood flow of the target vascular perfusion area based on the slope of the rising phase of the time-decay curve of the myocardial tissue in the myocardial perfusion area, the peak value and the target vascular area of ​​interest, and using the quantitative myocardial blood flow of the target vascular perfusion area as the myocardial blood flow MBF of the target vascular perfusion area in the case of stenosis hyper-stenosis .

[0016] According to another specific embodiment of the present invention, the quantitative myocardial blood flow of the target blood vessel perfusion area includes at least one of the mean and median of the myocardial blood flow of the normal perfusion area of ​​the target blood vessel, and / or the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel includes at least one of the mean and median of the myocardial blood flow of the normal perfusion area of ​​the target blood vessel.

[0017] According to another specific embodiment of the present invention, the myocardial blood flow MBF of the target vascular perfusion area under stenosis is hyper-stenosis MBF and target vascular perfusion area in simulated normal myocardial blood flow hyper-normal Get MBF hyper-stenosis and MBF hyper-normal The ratio of CTP-FFR is used as the ratio of blood flow in the diseased state and the healthy state:

[0018]

[0019] The CTP-FFR value is used to evaluate the proportion of myocardial ischemia caused by coronary artery stenosis. The proportion of myocardial ischemia caused by coronary artery stenosis is (1-CTP-FFR)*100%.

[0020] According to another specific embodiment of the present invention, based on the first image and the second image, the left ventricular myocardial area is mapped to each blood vessel in the coronary artery vascular tree by an image processing method to obtain a mapping image, including: segmenting the first image by a first image segmentation algorithm to obtain a coronary artery vascular tree image, segmenting the second image by a second image segmentation algorithm to obtain a left ventricular myocardial structure image; registering the first image and the second image by an image registration method to obtain a registered image, the registered image being the registered first image; mapping the left ventricular myocardial structure area of ​​the left ventricular myocardial structure image to each blood vessel of the coronary artery vascular tree in the coronary artery vascular tree image by an image mapping method based on the registered image and the second image to obtain a mapping image.

[0021] According to another specific embodiment of the present invention, the left ventricular myocardial structure area of ​​the left ventricular myocardial structure image is mapped to each blood vessel of the coronary artery vascular tree in the coronary artery vascular tree image by an image mapping method according to the registered image and the second image to obtain a mapping image, including: mapping the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree by bifurcation principle mapping to obtain a mapping image; mapping the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree by bifurcation principle mapping to obtain a mapping image, preferably, further including: mapping the left ventricular myocardial area to all coronary arteries with a lumen diameter ≥1 mm in the coronary artery vascular tree by the principle of divide and conquer.

[0022] In a second aspect, an embodiment of the present invention discloses a myocardial ischemia assessment system, comprising: an image acquisition module, used to acquire a first image and a second image, the first image being a coronary CT angiography image CCTA, and the second image being a CT myocardial perfusion image CTP under load; an image processing module, used to map the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree according to the first image and the second image by an image processing method to obtain a mapping image; an image calibration module, used to calibrate the target vascular perfusion area in the mapping image; a myocardial blood flow acquisition module for the target vascular perfusion area, used to acquire a time-attenuation curve of the myocardial tissue in the myocardial perfusion area according to the second image, acquire a quantitative myocardial blood flow in the target vascular perfusion area based on the time-attenuation curve of the myocardial tissue and the target vascular perfusion area, and use the quantitative myocardial blood flow in the target vascular perfusion area as the myocardial blood flow MBF of the target vascular perfusion area under stenosis. hyper - stenosis ; Used to obtain the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel, and use the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel as the myocardial blood flow MBF of the target blood vessel perfusion area under simulated normal conditions hyper-normal ; Myocardial ischemia assessment module, used to evaluate myocardial blood flow (MBF) in the target vascular perfusion area under stenosis hyper-stenosisMBF and target vascular perfusion area in simulated normal myocardial blood flow hyper-normal , CTP-FFR is used to evaluate the proportion of myocardial ischemia caused by coronary artery stenosis.

[0023] By adopting the above technical scheme, the image acquisition module, the image processing module, the image calibration module, the myocardial blood flow acquisition module of the target vascular perfusion area and the myocardial ischemia assessment module cooperate with each other to perform non-invasive assessment of myocardial ischemia based only on the first image and the second image. The myocardial ischemia assessment system can quantify the degree of ischemia caused by epicardial vascular stenosis without the aid of fluid mechanics. In addition, the present invention evaluates the ischemic condition of actual myocardial perfusion through CTP-FFR, and has the advantages of rapid, accurate and reliable quantitative assessment of overall myocardial ischemia.

[0024] According to another specific embodiment of the present invention, the myocardial blood flow acquisition module of the target vascular perfusion area is used to obtain the quantitative myocardial blood flow of the target vascular perfusion area based on the slope of the rising period of the time-decay curve of the myocardial tissue in the myocardial perfusion area, the peak value and the target vascular area of ​​interest, and the quantitative myocardial blood flow of the target vascular perfusion area is used as the myocardial blood flow MBF of the target vascular perfusion area in the case of stenosis. hyper-stenosis .

[0025] According to another specific embodiment of the present invention, the quantitative myocardial blood flow of the target blood vessel perfusion area includes at least one of the mean and median of the myocardial blood flow of the normal perfusion area of ​​the target blood vessel, and / or the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel includes at least one of the mean and median of the myocardial blood flow of the normal perfusion area of ​​the target blood vessel.

[0026] According to another specific embodiment of the present invention, the myocardial ischemia assessment module is used to evaluate the myocardial blood flow (MBF) of the target vascular perfusion area under stenosis. hyper-stenosis MBF and target vascular perfusion area in simulated normal myocardial blood flow hyper-normal Get MBF hyper-stenosis and MBF hyper-normal The ratio of CTP-FFR is used as the ratio of blood flow in the diseased state and the healthy state:

[0027]

[0028] The CTP-FFR value is used to evaluate the proportion of myocardial ischemia caused by coronary artery stenosis. The proportion of myocardial ischemia caused by coronary artery stenosis is (1-CTP-FFR)*100%.

[0029] According to another specific embodiment of the present invention, the image processing module includes: an image segmentation module, which is used to segment the first image through a first image segmentation algorithm to obtain a coronary artery vascular tree image, and segment the second image through a second image segmentation algorithm to obtain a left ventricular myocardial structure image; an image registration module, which is used to register the first image and the second image through an image registration method to obtain a registered image, and the registered image is the registered first image; an image mapping module, which is used to map the left ventricular myocardial structure area of ​​the left ventricular myocardial structure image to each blood vessel of the coronary artery vascular tree in the coronary artery vascular tree image through an image mapping method according to the registered image and the second image to obtain a mapped image.

[0030] According to another specific embodiment of the present invention, the image mapping module is used to map the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree through bifurcation principle mapping to obtain a mapping image. Further, the image mapping module is used to map the left ventricular myocardial area to all coronary arteries with a lumen diameter ≥ 1 mm in the coronary artery vascular tree through the divide-and-conquer principle.

[0031] In a third aspect, the present invention provides a method for evaluating microcirculatory disorders, comprising: obtaining the proportion of myocardial ischemia caused by coronary artery stenosis CTP-FFR by the myocardial ischemia evaluation method as in any embodiment of the first aspect; obtaining the proportion of myocardial ischemia caused by epicardial vascular stenosis CT-FFR according to the CT-FFR method for evaluating epicardial vascular stenosis; evaluating the proportion of microcirculatory disorders ΔCT-FFR according to the proportion of myocardial ischemia caused by coronary artery stenosis CTP-FFR and the proportion of myocardial ischemia caused by epicardial vascular stenosis CT-FFR:

[0032] △CT-FFR=CT-FFR-CTP-FFR formula 2.

[0033] Using the above technical solution, since CT-FFR evaluates ischemia caused by epicardial vascular stenosis, and CTP-FFR can evaluate the ischemia of actual myocardial perfusion, the numerical difference between CT-FFR and CTP-FFR is used to indicate the degree of ischemia caused by microcirculatory disorders. This is simple and efficient, and since the microcirculatory disorder evaluation method adopts a non-invasive approach, it is safer.

[0034] In a fourth aspect, the present invention provides a microcirculation disorder assessment system, comprising: a myocardial ischemia assessment module, for obtaining a proportion of myocardial ischemia CTP-FFR caused by coronary artery stenosis by a myocardial ischemia assessment method as in any embodiment of the first aspect; the myocardial ischemia assessment module is further used to obtain a proportion of myocardial ischemia CT-FFR caused by epicardial vascular stenosis according to a CT-FFR method for assessing epicardial vascular stenosis; a microcirculation disorder assessment module, for assessing a microcirculation disorder proportion ΔCT-FFR according to the proportion of myocardial ischemia CTP-FFR caused by coronary artery stenosis and the proportion of myocardial ischemia CT-FFR caused by epicardial vascular stenosis obtained by the myocardial ischemia assessment module:

[0035] △CT-FFR=CT-FFR-CTP-FFR formula 2.

[0036] By adopting the above technical scheme, CT-FFR and CTP-FFR are obtained through the joint action of the myocardial ischemia assessment module and the microcirculation disorder assessment module. Since CT-FFR assesses ischemia caused by epicardial vascular stenosis, and CTP-FFR can assess the ischemia of actual myocardial perfusion, the numerical difference between CT-FFR and CTP-FFR indicates the degree of ischemia caused by microcirculation disorder. This is simple and efficient, and since the microcirculation disorder assessment system adopts a non-invasive method, it is safer.

[0037] In a fifth aspect, the present invention provides a method for calculating microcirculatory resistance, comprising: obtaining the aortic pressure P of the coronary system through the systolic and diastolic pressures of the target object; 0 ; Obtain the venous pressure P of the coronary system 2 , the venous pressure P of the coronary system under load 2 5 mmHg; obtaining a second image, which is a CT myocardial perfusion image CTP under load; according to the second image, obtaining the myocardial blood flow MBF of the target vascular perfusion area under stenosis by the myocardial ischemia assessment method in any embodiment of the first aspect. hyper-stenosis , obtain the myocardial blood flow (MBF) of the target vascular perfusion area under simulated normal conditions hyper-normal ; According to the aortic pressure P of the coronary system 0 , venous pressure P of the coronary system 2 , Myocardial blood flow (MBF) in the target vascular perfusion area under simulated normal conditions hyper-normal Obtain the resistance R of microcirculation to blood flow under normal conditions; according to the aortic pressure P of the coronary system 0 , the ratio of myocardial ischemia caused by epicardial vascular stenosis obtained by the microcirculatory disorder evaluation method in any embodiment of the third aspect, and the pressure P of the distal epicardial blood vessel 1; According to the pressure P at the distal end of the epicardial vessels 1 , venous pressure P of the coronary system 2 , myocardial blood flow (MBF) in the target vascular perfusion area under stenosis hyper-stenosis , the resistance R caused by microcirculation to blood flow under normal conditions, the aortic pressure P of the coronary system 0 Obtain the resistance R caused by microcirculatory disorders to blood flow 2 .

[0038] The above technical solution takes into account the resistance of the coronary microcirculation under normal conditions, and only calculates the resistance caused by microcirculatory disorders. This means that the evaluation not only takes into account the impact of epicardial vascular stenosis on blood flow, but also the inherent resistance of the microcirculation itself. This method can more accurately evaluate the impact of microcirculatory disorders on myocardial perfusion, thereby providing a more comprehensive assessment of myocardial ischemia.

[0039] According to another specific embodiment of the present invention, according to the aortic pressure P of the coronary system 0 , venous pressure P of the coronary system 2 , Myocardial blood flow (MBF) in the target vascular perfusion area under simulated normal conditions hyper-normal The resistance R caused by microcirculation to blood flow under normal conditions is obtained by calculation:

[0040]

[0041] Alternatively, according to the aortic pressure P of the coronary system 0 , the ratio of myocardial ischemia caused by epicardial vascular stenosis obtained by the microcirculatory disorder evaluation method in any embodiment of the third aspect, and the pressure P of the distal epicardial blood vessel 1 , calculated as:

[0042] P 1 =P 0 *CT-FFR formula 4.

[0043] According to another specific embodiment of the present invention, according to the pressure P at the distal end of the epicardial blood vessel 1 , venous pressure P of the coronary system 2 , myocardial blood flow (MBF) in the target vascular perfusion area under stenosis hyper-stenosis , the resistance R caused by microcirculation to blood flow under normal conditions, the aortic pressure P of the coronary system 0 Obtain the resistance R caused by microcirculatory disorders to blood flow 2 , calculated as:

[0044]

[0045] According to another specific embodiment of the present invention, the aortic pressure P of the coronary system is obtained by the systolic and diastolic pressures of the target subject. 0 , including at least one of the following calculation methods: aortic pressure P 0 = diastolic pressure + 1 / 3 (systolic pressure - diastolic pressure) + 5 mmHg; aortic pressure P 0 = diastolic blood pressure + 0.412 (systolic blood pressure - diastolic blood pressure).

[0046] In a sixth aspect, the present invention provides a system for calculating microcirculatory resistance, including: a data acquisition module for acquiring aortic pressure P of the coronary system through systolic pressure and diastolic pressure of the target object; 0 ; Obtain the venous pressure P of the coronary system 2 , the venous pressure P of the coronary system under load 2 5 mmHg; an image acquisition and analysis module, used to acquire a second image, the second image being a CT myocardial perfusion image CTP under load; according to the second image, the myocardial blood flow MBF of the target vascular perfusion area under stenosis is acquired by the myocardial ischemia assessment method in any embodiment of the first aspect described above. hyper-stenosis , obtain the myocardial blood flow (MBF) of the target vascular perfusion area under simulated normal conditions hyper-normal ; Data processing module, used to calculate the aortic pressure P of the coronary system 0 , venous pressure P of the coronary system 2 , Myocardial blood flow (MBF) in the target vascular perfusion area under simulated normal conditions hyper-normal Obtain the resistance R of microcirculation to blood flow under normal conditions; used to calculate the aortic pressure P of the coronary system 0 , the ratio of myocardial ischemia caused by epicardial vascular stenosis obtained by the microcirculatory disorder evaluation method of any embodiment of the second aspect, and the pressure P of the distal epicardial blood vessel 1 ; used to calculate the pressure P at the distal end of the epicardial vessels 1 , venous pressure P of the coronary system 2 , myocardial blood flow (MBF) in the target vascular perfusion area under stenosis hyper-stenosis , the resistance R caused by microcirculation to blood flow under normal conditions, the aortic pressure P of the coronary system 0 Obtain the resistance R caused by microcirculatory disorders to blood flow 2 .

[0047] Using the above technical solution, the calculation system of microcirculatory disorder resistance takes into account the resistance of the coronary microcirculation under normal conditions, and only calculates the resistance caused by microcirculatory disorder. This means that the evaluation not only takes into account the impact of epicardial vascular stenosis on blood flow, but also the inherent resistance of the microcirculation itself. The system can more accurately evaluate the impact of microcirculatory disorders on myocardial perfusion, thereby providing a more comprehensive assessment of myocardial ischemia.

[0048] According to another specific embodiment of the present invention, according to the aortic pressure P of the coronary system 0 , venous pressure P of the coronary system 2 , Myocardial blood flow (MBF) in the target vascular perfusion area under simulated normal conditions hyper-normal The resistance R caused by microcirculation to blood flow under normal conditions is obtained by calculation:

[0049]

[0050] Alternatively, according to the aortic pressure P of the coronary system 0 , the ratio of myocardial ischemia caused by epicardial vascular stenosis obtained by the microcirculatory disorder evaluation method in any embodiment of the third aspect, and the pressure P of the distal epicardial blood vessel 1 , calculated as:

[0051] P 1 =P 0 *CT-FFR formula 4.

[0052] According to another specific embodiment of the present invention, according to the pressure P at the distal end of the epicardial blood vessel 1 , venous pressure P of the coronary system 2 , myocardial blood flow (MBF) in the target vascular perfusion area under stenosis hyper-stenosis , the resistance R caused by microcirculation to blood flow under normal conditions, the aortic pressure P of the coronary system 0 Obtain the resistance R caused by microcirculatory disorders to blood flow 2 , calculated as:

[0053]

[0054] According to another specific embodiment of the present invention, the aortic pressure P of the coronary system is obtained by the systolic and diastolic pressures of the target subject. 0 , including at least one of the following calculation methods: aortic pressure P 0 = diastolic pressure + 1 / 3 (systolic pressure - diastolic pressure) + 5 mmHg; aortic pressure P 0 = diastolic blood pressure + 0.412 (systolic blood pressure - diastolic blood pressure).

[0055] The beneficial effects of the present invention are as follows:

[0056] 1. The present invention proposes a non-invasive assessment method for myocardial ischemia based only on imaging, which can quantify the degree of ischemia caused by epicardial vascular stenosis without the aid of fluid mechanics.

[0057] The myocardial ischemia assessment method provided by the present invention calculates the ratio of myocardial ischemia caused by coronary artery stenosis CTP-FFR by processing the first image (i.e., coronary CT angiography CCTA) and the second image (CT myocardial perfusion CTP under load), and using the myocardial blood flow MBF obtained by the second image CTP. In other words, the myocardial ischemia assessment method provided by the present invention directly obtains CTP-FFR based on the image processing of CTP, thereby quantifying the degree of ischemia caused by epicardial vascular stenosis.

[0058] Compared with calculating CT-FFR through CT images, the present invention provides a non-invasive assessment method for myocardial ischemia based only on imaging, that is, the myocardial ischemia assessment method can obtain CTP-FFR directly based on the image processing of CTP. CTP-FFR is the blood flow reserve fraction based on the CT myocardial perfusion image CTP under load state, which realizes the quantification of the degree of ischemia caused by epicardial vascular stenosis. The myocardial ischemia assessment method provided by the present invention does not require the use of fluid mechanics. Since mechanical simulation is a simulation calculation, the assessment of myocardial ischemia obtained according to mechanical simulation is a simulation result. Compared with the assessment of myocardial ischemia obtained according to mechanical simulation, the results obtained by the image processing-based quantification method of myocardial ischemia provided by the present invention are more accurate and faster. The present invention evaluates the ischemic condition of actual myocardial perfusion through CTP-FFR, and has the advantages of rapid and accurate quantitative assessment of overall myocardial ischemia.

[0059] 2. The myocardial ischemia assessment system provided by the present invention cooperates with an image acquisition module, an image processing module, an image calibration module, a myocardial blood flow acquisition module of the target vascular perfusion area and a myocardial ischemia assessment module to perform non-invasive assessment of myocardial ischemia based only on the first image and the second image. The myocardial ischemia assessment system can quantify the degree of ischemia caused by epicardial vascular stenosis without the aid of fluid mechanics. The present invention evaluates the ischemic condition of actual myocardial perfusion through CTP-FFR, and has the advantages of rapid, accurate and reliable quantitative assessment of overall myocardial ischemia.

[0060] 3. The present invention provides a method and system for evaluating microcirculatory disorders, which evaluates the proportion of microcirculatory disorders ΔCT-FFR through the proportion of myocardial ischemia caused by coronary artery stenosis CTP-FFR and the proportion of myocardial ischemia caused by epicardial vascular stenosis CT-FFR. Since CT-FFR evaluates ischemia caused by epicardial vascular stenosis, and CTP-FFR can evaluate the ischemia of actual myocardial perfusion, the numerical difference between CT-FFR and CTP-FFR indicates the degree of ischemia caused by microcirculatory disorders, which is simple and efficient, and since the microcirculatory disorder evaluation method adopts a non-invasive method, it is safer.

[0061] 4. The present invention proposes a non-invasive assessment method for myocardial ischemia based on imaging to achieve quantitative assessment of microcirculatory resistance. The calculation method and system for microcirculatory obstruction resistance provided by the present invention take into account the resistance of the microcirculation of the coronary artery under normal conditions, and only calculate the resistance caused by microcirculatory obstruction. This means that the assessment not only takes into account the effect of epicardial vascular stenosis on blood flow, but also takes into account the inherent resistance of the microcirculation itself. This method can more accurately assess the impact of microcirculatory obstruction on myocardial perfusion, thereby providing a more comprehensive assessment of myocardial ischemia. BRIEF DESCRIPTION OF THE DRAWINGS

[0062] Figure 1 The process of the myocardial ischemia assessment method in the embodiment of the present invention is shown as follows: Figure 1 ;

[0063] Figure 2 The coronary CT angiography CCTA image in an embodiment of the present invention is shown;

[0064] Figure 3 The CT myocardial perfusion image CTP under load state in an embodiment of the present invention is shown;

[0065] Figure 4 The myocardial blood flow image MBF in an embodiment of the present invention is shown;

[0066] Figure 5 The process of the myocardial ischemia assessment method in the embodiment of the present invention is shown as follows: Figure 2 ;

[0067] Fig. 6A FIG. 1 shows another embodiment of the present invention, a coronary CT angiography image, CCTA. 1 ;

[0068] Figure 6B FIG. 2 shows another embodiment of the present invention, a coronary CT angiography image II CCTA 2 ;

[0069] Figure 7 FIG. 2 shows a second coronary artery tree image according to another embodiment of the present invention;

[0070] Fig. 8A Shows a left ventricular myocardial structure image 1 in another embodiment of the present invention;

[0071] Figure 8B Shows a second left ventricular myocardial structure image according to another embodiment of the present invention;

[0072] Fig. 9 FIG. 1 shows a coronary artery tree image 1 according to an embodiment of the present invention;

[0073] Fig. 10A shows a registered image in one embodiment of the present invention;

[0074] Fig. 10B A mapping image of each blood vessel in the coronary artery tree and the left ventricular myocardial area is shown in one embodiment of the present invention;

[0075] Fig.11 A time-decay curve diagram of myocardial tissue in a myocardial perfusion area according to an embodiment of the present invention is shown;

[0076] Fig.12 The process of the myocardial ischemia assessment method in the embodiment of the present invention is shown as follows: Figure 3 ;

[0077] Fig.13 The VoxelMorph registration algorithm flow and the UNet structure type network design in the embodiment of the present invention are shown;

[0078] Fig.14 A schematic diagram showing the structure of a myocardial ischemia assessment system according to an embodiment of the present invention is shown;

[0079] Fig.15 A flow chart showing a method for evaluating microcirculatory disorders in an embodiment of the present invention;

[0080] Fig.16 A schematic diagram showing the structure of a microcirculation disorder assessment system according to an embodiment of the present invention is shown;

[0081] Fig.17 A flow chart showing a method for calculating microcirculatory disturbance in an embodiment of the present invention;

[0082] Fig.18 A schematic diagram showing the physical relationship between the pressure and blood flow of the coronary system in an embodiment of the present invention;

[0083] Fig.19 A schematic diagram showing the structure of a microcirculation disorder calculation system according to an embodiment of the present invention is shown;

[0084] Fig. 20 A schematic structural diagram of an electronic device in an embodiment of the present invention is shown. DETAILED DESCRIPTION

[0085] The following specific embodiments illustrate the implementation of the present invention, and those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. Although the description of the present invention will be introduced in conjunction with the preferred embodiment, this does not mean that the features of this invention are limited to this implementation. On the contrary, the purpose of introducing the invention in conjunction with the implementation is to cover other options or modifications that may extend based on the claims of the present invention. In order to provide a deep understanding of the present invention, many specific details will be included in the following description. The present invention can also be implemented without using these details. In addition, in order to avoid confusion or blurring the focus of the present invention, some specific details will be omitted in the description. It should be noted that the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.

[0086] It should be noted that in this specification, similar reference numerals and letters denote similar items in the following drawings, and therefore, once an item is defined in one drawing, it does not need to be further defined and explained in the subsequent drawings.

[0087] The terms “first”, “second”, etc. are only used for distinguishing descriptions and should not be understood as indicating or implying relative importance.

[0088] In the description of this embodiment, it is also necessary to explain that, unless otherwise clearly specified and limited, the terms "set", "connected", and "connected" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or it can be indirectly connected through an intermediate medium, or it can be the internal communication of two components. For ordinary technicians in this field, the specific meanings of the above terms in this embodiment can be understood according to specific circumstances.

[0089] In order to make the objectives, technical solutions and advantages of the present invention more clear, the embodiments of the present invention will be further described in detail below with reference to the accompanying drawings.

[0090] The myocardial ischemia assessment method and system, microcirculation disorder assessment method and system, microcirculation disorder calculation method and system, electronic device and computer storage medium provided by the present invention all have non-therapeutic purposes.

[0091] The myocardial ischemia assessment method and system, microcirculation disorder assessment method and system, and microcirculation disorder calculation method and system provided by the present invention are all based on the processing of medical images, that is, their direct objects are medical images, such as CCTA and CTP.

[0092] First, reference Figure 1 The present invention provides a method for evaluating myocardial ischemia, comprising:

[0093] S1: Acquire a first image and a second image.

[0094] In this embodiment, the first image is a coronary CT angiography image CCTA, and the second image is a CT myocardial perfusion image CTP under load.

[0095] Among them, Figure 2 As shown, the first image, Coronary Computed Tomography Angiography (CCTA), is a non-invasive imaging method used to check for stenosis or blockage in the coronary arteries. This test uses special X-rays and computer processing technology to generate high-resolution images of the heart and coronary arteries. CCTA images are collected under non-load conditions, such as images collected without loading drugs, in order to show the coronary artery structure.

[0096] like Figure 3 As shown in the figure, the second image is the CT myocardial perfusion image CTP under stress, which is a state in which the heart load is increased by drugs or exercise. Since whether the myocardium is truly ischemic is defined under stress, this test is usually performed when the patient undergoes a stress test, such as using a drug-induced increase in heart rate or using exercise to increase the heart load. This state can simulate the working state of the heart in actual activities, thereby better evaluating the blood supply to the heart and the perfusion of the myocardium. CT myocardial perfusion image CTP is a non-invasive imaging method that can image the myocardium to evaluate the blood supply to the heart and the perfusion of the myocardium. The perfusion of the heart, including the distribution of blood flow and any possible ischemic areas. This information is very important for diagnosing coronary artery disease, assessing cardiac risk and formulating treatment plans. Figure 4 The figure shows the myocardial blood flow (MBF) obtained from CT myocardial perfusion images (CTP) under stress conditions.

[0097] S2: According to the first image and the second image, the left ventricular myocardial area is mapped to each blood vessel in the coronary artery vascular tree by an image processing method to obtain a mapping image.

[0098] In this embodiment, Figure 2 A first image, a coronary CT angiogram CCTA, is shown. Figure 3 The second image is shown, namely, a CT myocardial perfusion image CTP under stress state. Fig. 10B The mapping image is shown, which shows the mapping relationship between the left ventricular myocardial area and each blood vessel in the coronary artery vascular tree. Step S2 is performed according to Figure 2 The first image and Figure 3 The second image shown is obtained as Fig. 10BMapping image shown.

[0099] For example, reference Fig. 10B , vessel b in the coronary artery vascular tree corresponds to left ventricular myocardial area B, vessel c in the coronary artery vascular tree corresponds to left ventricular myocardial area C, vessel d in the coronary artery vascular tree corresponds to left ventricular myocardial area D, and vessel e in the coronary artery vascular tree corresponds to left ventricular myocardial area E.

[0100] Continue to refer Figure 1 , executing step S3: calibrating the target vascular perfusion area in the mapping image.

[0101] Step S3 implements the calibration of the pixel points of the target blood vessel perfusion area on the mapping image.

[0102] In image processing, calibration refers to the process of determining the correspondence between the pixels in an image and the actual physical dimensions in the world through a series of mathematical processes. Simply put, the purpose of calibration is to enable the computer to accurately obtain the actual size information from the image. Before image calibration, the computer processes pixel-level information, which cannot be directly converted into physical dimensions such as length and width in the real world. Once the calibration is completed, these parameters can be used to convert the pixel coordinates in the image to the coordinate system of the real world to achieve functions such as length measurement and position positioning.

[0103] Continue to refer Figure 1 , executing step S4: acquiring the time-attenuation curve of the myocardial tissue in the myocardial perfusion area according to the second image, acquiring the quantitative myocardial blood flow of the target vascular perfusion area based on the time-attenuation curve of the myocardial tissue and the target vascular perfusion area, and using the quantitative myocardial blood flow of the target vascular perfusion area as the myocardial blood flow MBF of the target vascular perfusion area in the case of stenosis hyper-stenosis .

[0104] Step S4 realizes obtaining the myocardial blood flow MBF of each pixel point on the second image.

[0105] Furthermore, the myocardial blood flow MBF of each pixel point on the second image obtained in step S4 includes the pixel points of the target vascular perfusion area calibrated on the mapping image in step S3. That is to say, the myocardial blood flow MBF of each pixel point on the second image has a spatial mapping relationship with the pixel points of the target vascular perfusion area calibrated on the mapping image. The myocardial blood flow MBF of the target vascular perfusion area can be obtained by mapping the pixel points of the target vascular perfusion area to the myocardial blood flow MBF of each pixel point in the corresponding area on the second image, and the target vascular perfusion area is also the stenotic vascular area. In this embodiment, the mean of the myocardial blood flow of the target vascular perfusion area is calculated and used as the myocardial blood flow MBF of the target vascular perfusion area under stenosis.hyper-stenosis .

[0106] In some other possible embodiments, the median of the myocardial blood flow in the target vascular perfusion area is calculated, and the median is used as the myocardial blood flow MBF in the target vascular perfusion area under stenosis. hyper-stenosis .

[0107] The time-attenuation curve of myocardial tissue in the myocardial perfusion area refers to a curve obtained by observing and recording the changes in the absorption and attenuation of radioactive tracers by myocardial tissue over time during myocardial perfusion imaging. This curve can reflect the perfusion of myocardial tissue at different times, that is, the blood supply. By analyzing this curve, we can understand the temporal and spatial distribution of myocardial perfusion and evaluate the functional state of myocardial perfusion, which is of great significance for diagnosing the severity of coronary heart disease and evaluating the treatment effect.

[0108] In this embodiment, the time-attenuation curve of the myocardial tissue in the myocardial perfusion area obtained according to the second image is as follows: Fig.11 As shown. The horizontal axis is time, in seconds; the vertical axis is the attenuation value, in MBq (megabecquerel). The arterial input curve shows the attenuation of the signal intensity or the activity of the radionuclide in the aorta over time; the myocardial curve shows the attenuation of the signal intensity or the activity of the radionuclide in the myocardium over time.

[0109] Execute step S5: obtain the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel, and use the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel as the myocardial blood flow MBF of the perfusion area of ​​the target blood vessel under simulated normal conditions. hyper-normal .

[0110] The second image can directly distinguish the stenotic vascular area from the normal vascular area. According to the myocardial blood flow MBF of each pixel point in the normal vascular area, in this embodiment, the mean value of the myocardial blood flow of each pixel point in the normal vascular area is calculated and used as the myocardial blood flow MBF of the target vascular perfusion area under simulated normal conditions. hyper-normal .

[0111] In some possible embodiments provided by the present invention, the quantitative myocardial blood flow of the target blood vessel perfusion area includes at least one of the mean and median of the myocardial blood flow of the normal perfusion area of ​​the target blood vessel, and / or the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel includes at least one of the mean and median of the myocardial blood flow of the normal perfusion area of ​​the target blood vessel.

[0112] That is to say, the following three technical solutions are included. Technical Solution 1: The quantitative myocardial blood flow in the perfused area of ​​the target vessel includes at least one of the mean and median of the myocardial blood flow in the normal perfused area of ​​the target vessel, and the quantitative myocardial blood flow in the normal perfused area of ​​the target vessel includes at least one of the mean and median of the myocardial blood flow in the normal perfused area of ​​the target vessel. Technical Solution 2: The quantitative myocardial blood flow in the perfused area of ​​the target vessel includes at least one of the mean and median of the myocardial blood flow in the normal perfused area of ​​the target vessel. Technical Solution 3: The quantitative myocardial blood flow in the normal perfused area of ​​the target vessel includes at least one of the mean and median of the myocardial blood flow in the normal perfused area of ​​the target vessel.

[0113] In this embodiment, the mean is selected to represent the myocardial blood flow in the normally perfused area of ​​the target blood vessel. The selection of the mean is based on the following considerations: First, the mean can provide a measure of the average level of myocardial blood flow in a region or group, which is considered to be the general level of myocardial blood flow in the region and is statistically representative. Secondly, in actual clinical applications, the mean is a simple quantitative indicator that allows doctors or researchers to quickly understand the status of myocardial perfusion. Furthermore, the mean can integrate information from multiple different perfusion areas, thereby reducing the impact of abnormal values ​​in individual areas on the overall assessment. Even if some areas may show different perfusion levels due to local lesions or other factors, the overall mean can still provide a relatively stable estimate.

[0114] In some other possible embodiments, the median of the myocardial blood flow in the normal perfusion area of ​​the target vessel is calculated, and the median is used as the myocardial blood flow MBF of the perfusion area of ​​the target vessel in the case of stenosis. hyper-stenosis .

[0115] The median myocardial blood flow in the target vascular perfusion area is taken as the myocardial blood flow MBF in the target vascular perfusion area under stenosis. hyper-stenosis The following factors are taken into consideration: when there are many numerically abnormal pixels in the region of interest of the image, there will be significant deviations in the statistical measurement based on the mean. At this time, the use of the median can effectively eliminate or weaken the interference caused by the abnormal pixels, and more truly reflect the overall situation of myocardial blood flow in the target area, thereby improving the accuracy and reliability of the analysis.

[0116] The median of the myocardial blood flow in the normal perfusion area of ​​the target vessel is taken as the myocardial blood flow MBF of the target vessel perfusion area under simulated normal conditions. hyper-normalThe following factors are taken into consideration: when there are many numerically abnormal pixels in the region of interest of the image, there will be significant deviations in the statistical measurement based on the mean. At this time, the use of the median can effectively eliminate or weaken the interference caused by the abnormal pixels, and more truly reflect the overall situation of myocardial blood flow in the target area, thereby improving the accuracy and reliability of the analysis.

[0117] Execute step S6: according to the myocardial blood flow MBF of the target vascular perfusion area under the condition of stenosis hyper-stenosis MBF and target vascular perfusion area in simulated normal myocardial blood flow hyper-normal , CTP-FFR is used to evaluate the proportion of myocardial ischemia caused by coronary artery stenosis.

[0118] That is, MBF hyper-stenosis MBF is the myocardial blood flow in the target vascular perfusion area under stenosis. hyper - normal The target vascular perfusion area simulates the myocardial blood flow under normal conditions.

[0119] By adopting the above technical solution, the proportion of myocardial ischemia caused by coronary artery stenosis CTP-FFR is calculated by processing the first image and the second image and using the myocardial blood flow MBF obtained by the second image CTP. That is to say, the method for evaluating myocardial ischemia provided by the present invention is directly based on the image processing of CTP to obtain CTP-FFR, so as to quantify the degree of ischemia caused by epicardial vascular stenosis. Unlike CT-FFR, which is used to evaluate ischemia caused by epicardial vascular stenosis, CTP-FFR can more quickly, accurately and reliably quantitatively evaluate the ischemia of actual myocardial perfusion.

[0120] Compared with calculating CT-FFR through CT images, the present invention provides a non-invasive assessment method for myocardial ischemia based only on imaging, that is, the myocardial ischemia assessment method can obtain CTP-FFR directly based on CTP image processing, so as to quantify the degree of ischemia caused by epicardial vascular stenosis. The myocardial ischemia assessment method provided by the present invention does not require the use of fluid mechanics. Since mechanical simulation is a simulation calculation, the assessment of myocardial ischemia obtained according to mechanical simulation is a simulation result. Compared with the assessment of myocardial ischemia obtained according to mechanical simulation, the results obtained by the quantification method of myocardial ischemia based on image processing provided by the present invention are more accurate and faster. The present invention evaluates the ischemic condition of actual myocardial perfusion through CTP-FFR, and has the advantages of rapid and accurate quantitative assessment of overall myocardial ischemia.

[0121] refer to Figure 1In some possible embodiments provided by the present invention, step S4: obtaining a time-attenuation curve of myocardial tissue in a myocardial perfusion region according to the second image, obtaining a quantitative myocardial blood flow in the target vascular perfusion region based on the time-attenuation curve of the myocardial tissue and the target vascular perfusion region, and using the quantitative myocardial blood flow in the target vascular perfusion region as the myocardial blood flow MBF of the target vascular perfusion region in the case of stenosis hyper-stenosis ,include:

[0122] S41: Based on the rising slope and peak of the time-decay curve of the myocardial tissue in the myocardial perfusion area and the target vessel area of ​​interest, the quantitative myocardial blood flow in the target vessel perfusion area is obtained, and the quantitative myocardial blood flow in the target vessel perfusion area is used as the myocardial blood flow MBF in the target vessel perfusion area under stenosis. hyper-stenosis .

[0123] In this embodiment, since the rising slope of the contrast agent-time attenuation curve of the pixel point is related to the blood flow, the myocardial blood flow can be indirectly reflected by comparing the maximum slopes of the time-attenuation curves of the myocardium and the aorta during the contrast agent filling phase, and dividing the maximum slope of the myocardial curve by the maximum slope of the aortic curve.

[0124] In some possible embodiments provided by the present invention, the myocardial blood flow MBF of the target vascular perfusion area under stenosis is calculated. hyper-stenosis MBF and target vascular perfusion area in simulated normal myocardial blood flow hyper-normal , to assess the proportion of myocardial ischemia caused by coronary artery stenosis, including: myocardial blood flow (MBF) according to the target vascular perfusion area under stenosis hyper-stenosis MBF and target vascular perfusion area in simulated normal myocardial blood flow hyper-normal Get MBF hyper-stenosis and MBF hyper-normal The ratio of CTP-FFR is used as the ratio of blood flow in the diseased state and the healthy state:

[0125]

[0126] The CTP-FFR value is used to evaluate the proportion of myocardial ischemia caused by coronary artery stenosis. The proportion of myocardial ischemia caused by coronary artery stenosis is (1-CTP-FFR)*100%.

[0127] For example, a CTP-FFR result of 0.70 means that epicardial vascular stenosis under load will result in a blood flow reduction of (1-0.70)*100%, ie, 30%.

[0128] refer to Figure 5Step S2: According to the first image and the second image, the left ventricular myocardial area is mapped to each blood vessel in the coronary artery vascular tree by an image processing method to obtain a mapping image, including:

[0129] S21: Segment the first image using a first image segmentation algorithm to obtain a coronary artery vascular tree image, and segment the second image using a second image segmentation algorithm to obtain a left ventricular myocardial structure image.

[0130] Image segmentation algorithm is a key technology in the field of computer vision, which aims to subdivide digital images into several regions or objects. These algorithms usually work based on certain features of the image, such as pixel intensity, color, texture or other attributes. Common image segmentation algorithms include: threshold segmentation, edge detection, region growing, level set method, graph cut algorithm, cluster segmentation, deep learning method, etc.

[0131] Threshold segmentation identifies objects in an image by setting one or more thresholds. Regions with pixel values ​​above or below a specific threshold are classified as foreground or background.

[0132] Edge detection uses edge detection algorithms to find points in an image where brightness changes significantly. It is often used to identify object boundaries.

[0133] Region growing, an algorithm that gradually merges neighboring pixels to form objects based on similarity criteria, such as color or brightness similarity between pixels.

[0134] Level set methods use mathematical models to evolutionarily label objects in images. They define objects in the form of a zero level set and evolve this zero level set through diffusion and refocusing operations.

[0135] The graph cut algorithm, based on graph theory, regards image pixels as nodes in a graph and constructs a graph to find the optimal segmentation by minimizing the energy function.

[0136] Clustering segmentation, using clustering algorithms such as K-means to divide image pixels into multiple clusters, each cluster represents an object. The clustering algorithm does not depend on the boundary information of the image and can be used to separate the background and foreground.

[0137] Deep learning methods,With the development of deep learning, segmentation methods based on convolutional neural networks (CNNs),are becoming more and more popular.,For example, network architectures such as FCN (Fully Convolutional Network),,U-Net, and SegNet are designed to handle image segmentation tasks.

[0138] These methods perform well in processing complex scenes and achieving refined segmentation; morphology-based segmentation, through morphological operations such as dilation, erosion, opening and closing operations, can be used to enhance specific structures in the image and assist in segmentation.

[0139] In this embodiment, the first image segmentation algorithm is a deep learning algorithm, and the deep learning algorithm includes but is not limited to a U-Net deep learning network.

[0140] For example, Fig. 6A and Figure 6B A first image is shown, wherein Fig. 6A and Figure 6B The area indicated by A is the left ventricular myocardium area. Fig. 6A and Figure 6B The first image shown is obtained as Figure 7 Image of the coronary vessel tree is shown.

[0141] For example, reference Figure 2 and Fig. 9 , Figure 2 The first image is shown, segmented by the U-Net deep learning network Figure 2 The first image shown is obtained as Fig. 9 An image of the coronary artery vascular tree is shown.

[0142] In this embodiment, the second image segmentation algorithm is a traditional image segmentation method or a deep learning algorithm. The traditional image segmentation method includes but is not limited to a threshold segmentation algorithm, and the deep learning algorithm includes but is not limited to a U-Net deep learning network.

[0143] For example, Figure 3 The second image is shown, and the second image is segmented by a deep learning algorithm such as a U-Net deep learning network to obtain Fig. 8A and Figure 8B Image of left ventricular myocardial structure is shown.

[0144] It should be noted that the first segmentation algorithm used to segment the first image is different from the second segmentation algorithm used to segment the second image. For example, even though both the first segmentation algorithm and the second segmentation algorithm can use the U-Net deep learning network, since the U-Net deep learning network is only a model framework, the specific model parameters and detailed designs will be different due to the segmentation objects such as the first image and the second image, so the first segmentation algorithm is also different from the second segmentation algorithm.

[0145] In some other possible embodiments provided by the present invention, the first image and the second image may be segmented by other image segmentation methods not limited to the above, and the coronary artery tree image and the left ventricular myocardial structure image may be obtained respectively. The present invention does not limit the image segmentation method used, as long as the coronary artery tree image can be obtained by segmenting the first image, and the left ventricular myocardial structure image can be obtained by segmenting the second image.

[0146] Continue to refer Figure 5 , S22: registering the first image and the second image by an image registration method to obtain a registered image, where the registered image is the registered first image.

[0147] Image registration is a technique in computer vision and medical image processing that aims to align corresponding points in two images so that information from one image can be seen in the other. Image registration methods are often used to merge image data from different time points, different viewpoints, or different modalities.

[0148] The present invention does not limit the image registration method used, as long as the first image and the second image can be registered by the image registration method to obtain a registered image.

[0149] refer to Fig.13 , Fig.13 The CCTA image shown in is the first image. Fig.13 The CTP image shown in is the second image. Fig.13 The registered image shown in is the registered image, that is, the first image after registration.

[0150] Depend on Fig.13 It can be seen that there is no big difference between the first image, the second image and the registered image. This is because the first image and the second image are obtained in the same position of the patient. In other words, the same patient is scanned by CCTA first and then by CTP in the same position, that is, the patient's actual physical position does not change much, so the medical images collected are not much different. It is just that the patient's blood vessels are affected by factors such as breathing or heartbeat, which causes the collected medical images to shift at the pixel level.

[0151] Specifically, the heartbeat itself has a cardiac cycle. When collecting medical images of the same patient in the same position, they will be collected at the same relative position in different cardiac cycles to minimize the position change of the two images. However, the position change caused by the patient's breathing or breath holding state (such as sufficient breath holding at the beginning of the shooting, insufficient breath holding at the end of the shooting) is inevitable. Therefore, the first image and the second image collected have a position change or displacement at the pixel level. Therefore, it is necessary to register the first image and the second image to achieve the correspondence of the pixels of the two in spatial position.

[0152] Continue to refer Figure 5 S23: Mapping the left ventricular myocardial structure region of the left ventricular myocardial structure image to each blood vessel of the coronary artery vascular tree in the coronary artery vascular tree image by an image mapping method according to the registered image and the second image, to obtain a mapping image.

[0153] Image mapping is a technique that maps pixels in one image (called the source image) to corresponding locations in another image (called the target image). This mapping is often used in image processing, image analysis, computer vision, and medical imaging. Common image mapping methods include direct mapping, interpolation mapping, affine transformation mapping, learning-based mapping, inverse mapping, and optimization methods.

[0154] Direct mapping assumes that there is a one-to-one relationship between the pixels in the source image and the target image. The corresponding position of each pixel in the source image in the target image is calculated, and then the value of the pixel is directly mapped to the corresponding position in the target image.

[0155] Interpolation mapping, when direct mapping is not possible, for example, the resolution of the source image and the target image are different, an interpolation method can be used to calculate the value of each pixel in the target image. Common interpolation methods include nearest neighbor interpolation, bilinear interpolation, and bicubic interpolation.

[0156] Affine transformation mapping is based on geometric transformations such as rotation, scaling, translation, and tilt. It calculates the corresponding position of each pixel in the source image under the geometric transformation and then maps these positions to the target image.

[0157] Based on learning mapping, machine learning methods such as deep learning are used to learn the mapping relationship between source images and target images by training neural networks or other learning models. For example, a convolutional neural network (CNN) can be used to learn the transformation between images.

[0158] Inverse mapping, calculate the corresponding position of each pixel in the target image in the source image, and then map these positions to the source image. This method can improve the accuracy of the mapping in some cases.

[0159] Optimization method, by minimizing the difference between the source image and the target image, uses an optimization algorithm to calculate the mapping relationship. For example, mutual information maximization, gradient descent, etc. can be used to optimize the mapping.

[0160] For example, in this embodiment, according to the registered image, the left ventricular myocardial area is mapped to each blood vessel in the coronary artery tree based on the bifurcation principle. That is, the myocardial perfusion area corresponding to the blood vessel segment in the coronary artery tree is mapped, and the left ventricular range perfused by each blood vessel is obtained according to the distribution of the coronary artery tree.

[0161] Fig. 10A shows the registered image, Fig. 10B 1 shows the mapping of each vessel in the coronary artery tree to the left ventricular myocardial area. Fig. 10B, vessel b in the coronary artery vascular tree corresponds to left ventricular myocardial area B, vessel c in the coronary artery vascular tree corresponds to left ventricular myocardial area C, vessel d in the coronary artery vascular tree corresponds to left ventricular myocardial area D, and vessel e in the coronary artery vascular tree corresponds to left ventricular myocardial area E.

[0162] In some possible embodiments provided by the present invention, step S23: mapping the left ventricular myocardial structure region of the left ventricular myocardial structure image to each vessel of the coronary artery vascular tree in the coronary artery vascular tree image by an image mapping method according to the registered image and the second image to obtain a mapping image, comprises:

[0163] S231: Map the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree by bifurcation principle mapping to obtain a mapping image.

[0164] The bifurcation principle is a method used in mathematics and computer science to map and analyze complex network structures, especially for tree-like structures such as coronary arteries. In the field of cardiac medicine, this principle can be used to study and simulate the blood supply relationship between coronary arteries and myocardium.

[0165] In some other possible embodiments provided by the present invention, S231: mapping the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree by the bifurcation principle to obtain a mapping image, including:

[0166] S2311: Map the myocardial area of ​​the left ventricle to all coronary arteries with a lumen diameter ≥ 1 mm in the coronary artery tree using the divide-and-conquer principle.

[0167] In some other possible embodiments, the Voronoi algorithm may be used to map the myocardial area of ​​the left ventricle to all coronary arteries with a lumen diameter of ≥1 mm in the coronary artery tree.

[0168] In some possible embodiments provided by the present invention, step S22: registering the first image and the second image by an image registration method to obtain a registered image, wherein the registered image includes the coronary artery tree and the left ventricular myocardial area.

[0169] Among them, the image registration method includes: at least one of: registration based on traditional feature extraction method, registration based on deep learning feature extraction method and registration method based on deep learning direct learning geometric transformation.

[0170] The registration method based on the traditional feature extraction method uses operators such as SIFT (scale-invariant feature transform) to extract image features and transform the two images to align the feature points. This method is highly interpretable and has low hardware requirements. It can achieve high accuracy and efficiency when processing simpler tasks.

[0171] The registration method based on deep learning feature extraction is to train a deep learning network to extract image features to replace operators such as SIFT in traditional methods. When the traditional feature extraction algorithm contains many outliers or cannot match a sufficient number of feature points, a deep learning method can be used to improve the accuracy and stability of feature extraction. For example, when CT images have severe local geometric distortion and artifacts, shallow information such as grayscale and gradient is difficult to support accurate feature point matching, so a deep learning network can be used to extract high-dimensional semantic information of the image.

[0172] The registration method based on deep learning directly learning geometric transformation is to align two images directly through deep network learning geometric transformation, without the need for feature extraction and feature point matching, such as the VoxelMorph method. This method needs to be trained based on paired labeled data. When the amount of data is large enough, the model performance can be fully utilized to ensure its stability.

[0173] Exemplarily, in this embodiment, a deep learning-based registration method is used to register the first image and the second image, so that the first image and the second image are spatially aligned to obtain a registered image, and the registered image includes the coronary artery vascular tree and the left ventricular myocardial area.

[0174] refer to Fig.12 Step S22: registering the first image and the second image by an image registration method to obtain a registered image, wherein the registered image is the registered first image. The image registration method based on deep learning includes:

[0175] S221: Acquire a first image and use the first image as a source image.

[0176] S222: Acquire a second image and use the second image as a target image.

[0177] S223: Taking the source image and the target image as input, training the registration network, and obtaining the registration deformation field from the source image to the target image.

[0178] S224: Obtain the registered image through spatial transformation, and obtain a similarity loss function according to the registered image, the source image and the target image.

[0179] S225: Obtain a smooth regularization term loss function according to the gradients of the registered deformation field and the displacement field.

[0180] S226: Obtain a network loss function according to a similarity loss function and a smoothing regularization term loss function.

[0181] S227: The network loss function is minimized through training iterations, and when the network loss function converges, the final registration deformation field and the registered image are obtained.

[0182] By adopting the above technical solution, the first image and the second image are spatially aligned by registering them, and a registered image is obtained. Based on the registered image, the left ventricular myocardial area is mapped to each blood vessel in the coronary artery vascular tree, ensuring the reliability and accuracy of the mapping relationship.

[0183] In some possible embodiments provided by the present invention, the image registration method is a VoxelMorph method.

[0184] VoxelMorph is a popular medical image registration software that provides a fast and effective method for 3D image registration. VoxelMorph achieves image registration by using a learning-based optimization method. This method combines traditional gradient-based optimization and learning-based feature matching to automatically learn the transformation between the images to be registered. VoxelMorph uses a convolutional neural network (CNN) to estimate the non-rigid transformation between images, which allows it to handle complex transformations such as distortion, deformation, etc.

[0185] In some other possible embodiments provided by the present invention, the image registration method used is a registration based on a traditional feature extraction method or a registration based on a deep learning feature extraction method. The registration method based on the traditional feature extraction method uses operators such as SIFT (scale-invariant feature transform) to extract image features and transform the two images to align the feature points. This method has strong interpretability and low hardware requirements, and can achieve higher accuracy and efficiency when processing simpler tasks. The registration method based on deep learning feature extraction is to train a deep learning network to extract image features to replace operators such as SIFT in traditional methods. When the traditional feature extraction algorithm contains more outliers or cannot match a sufficient number of feature points, a deep learning method can be used to improve the accuracy and stability of feature extraction.

[0186] In some possible embodiments provided by the present invention, Fig.12Step S223 shown: taking the source image and the target image as input, training the registration network, and obtaining the registration deformation field from the source image to the target image, including: taking the source image and the target image as input, training the registration network of the U-Net network structure, and obtaining the registration deformation field from the source image to the target image.

[0187] In some possible embodiments provided by the present invention, Fig.12 Before step S224 shown, step S2241 is performed: obtaining the mean square error loss between the registered image and the target image according to the registered image and the target image.

[0188] In some possible embodiments provided by the present invention, Fig.12 Before step S225 shown, step S2251 is performed: the gradient of the displacement field u is calculated.

[0189] For example, reference Fig.12 , and combined with Fig.13 The registration algorithm flow and network design are described in detail in the VoxelMorph method. A UNet structure type network is used to generate a three-dimensional deformation field from CTP images to CCTA images, as follows:

[0190] S221: Acquire a first image CCTA and use the first image CCTA as a source image (f).

[0191] S222: Acquire the second image CTP and use the second image as the target image (m).

[0192] S223: Taking the source image (f) and the target image (m) as input, training the registration network gθ(f, m) of the U-Net network structure, and obtaining the registration deformation field (φ) from the source image to the target image.

[0193] S2241: Based on the registered image Get the mean square error loss between the target image (m) and the target image (m). The calculation method is:

[0194]

[0195] Among them, n is the number of pixels that need to be registered, y i is the gray value of the i-th pixel of the target image (m), The image after registration The gray value of the i-th pixel.

[0196] Continue to refer Fig.12 Combined with Fig.13 , S224: Obtain the registered image through spatial transformation According to the registered image The similarity loss function is obtained between the source image (f) and the target image (m). The calculation is as follows:

[0197]

[0198] Among them, (p) is each pixel, Ω is all the pixels, The image after registration The mean square error loss between the image and the target image (m).

[0199] Execute step S2251: Gradient of displacement field u The calculation method is as follows:

[0200]

[0201] in, is the partial derivative of displacement u with respect to x, is the partial derivative of displacement u with respect to y, is the partial derivative of displacement u with respect to z, and p is each pixel point.

[0202] Continue to refer Fig.12 Combined with Fig.13 , execute step S225: obtain the smooth regularization term loss function L according to the gradient of the registration deformation field (φ) and the displacement field u smooth (φ), calculated as follows:

[0203]

[0204] in, is the gradient of the displacement field u, (p) is each pixel, and Ω is all pixels.

[0205] S226: Based on the similarity loss function Smooth regularization loss function L smooth (φ) Obtain the network loss function L(d,m,φ), which is calculated as follows:

[0206]

[0207] Among them, λ is an adjustable parameter used to assign weights to the two loss functions.

[0208] S227: Minimize the network loss function L(f,m,φ) through training iterations. When the network loss function L(f,m,φ) converges, the final registration deformation field (φ) and the registered image are obtained.

[0209] Second, refer to Fig.14The embodiment of the present invention discloses a myocardial ischemia assessment system 01, comprising: an image acquisition module 011, an image processing module 012, an image calibration module 013, a myocardial blood flow acquisition module 014 of a target vascular perfusion area, and a myocardial ischemia assessment module 015.

[0210] The image acquisition module 011 is used to acquire a first image and a second image, wherein the first image is a coronary CT angiography image CCTA, and the second image is a CT myocardial perfusion image CTP under load.

[0211] The image processing module 012 is used to obtain the registration of the coronary artery tree and the left ventricular myocardial structure according to the first image and the second image.

[0212] The image processing module 012 includes an image segmentation module 0121, an image registration module 0122 and an image mapping module 0123.

[0213] The image segmentation module 0121 is used to segment the first image using a first image segmentation algorithm to obtain a coronary artery tree image, and to segment the second image using a second image segmentation algorithm to obtain a left ventricular myocardial structure image.

[0214] The image registration module 0122 is used to register the first image and the second image by using an image registration method to obtain a registered image, where the registered image is the registered first image.

[0215] The image mapping module 0123 is used to map the left ventricular myocardial structure area of ​​the left ventricular myocardial structure image to each blood vessel of the coronary artery vascular tree in the coronary artery vascular tree image through an image mapping method according to the registered image and the second image, so as to obtain a mapping image.

[0216] The image calibration module 013 is used to calibrate the target blood vessel perfusion area in the mapping image.

[0217] The myocardial blood flow acquisition module 014 of the target vascular perfusion area is used to obtain the time-attenuation curve of the myocardial tissue in the myocardial perfusion area according to the second image, obtain the quantitative myocardial blood flow of the target vascular perfusion area based on the time-attenuation curve of the myocardial tissue, and use the quantitative myocardial blood flow of the target vascular perfusion area as the myocardial blood flow MBF of the target vascular perfusion area in the case of stenosis. hyper-stenosis .

[0218] The myocardial blood flow acquisition module 014 of the target blood vessel perfusion area is used to obtain the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel, and use the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel as the myocardial blood flow MBF of the target blood vessel perfusion area under simulated normal conditions. hyper-normal .

[0219] Myocardial ischemia assessment module 015 is used to evaluate the myocardial blood flow (MBF) of the target vascular perfusion area under stenosis. hyper-stenosis MBF and target vascular perfusion area in simulated normal myocardial blood flow hyper-normal , CTP-FFR is used to evaluate the proportion of myocardial ischemia caused by coronary artery stenosis.

[0220] By adopting the above technical solution, the image acquisition module 011, the image processing module 012, the image calibration module 013, the myocardial blood flow acquisition module 014 of the target vascular perfusion area and the myocardial ischemia assessment module 015 cooperate with each other to directly obtain CTP-FFR based on the image processing of CTP, so as to quantify the degree of ischemia caused by epicardial vascular stenosis. Different from CT-FFR used to assess ischemia caused by epicardial vascular stenosis, CTP-FFR can more quickly, accurately and reliably quantitatively assess the ischemia of actual myocardial perfusion.

[0221] Compared with calculating CT-FFR through CT images, the present invention provides a non-invasive myocardial ischemia assessment system 01 that is directly based only on imaging, that is, the myocardial ischemia assessment system 01 can obtain CTP-FFR directly based on CTP image processing, thereby quantifying the degree of ischemia caused by epicardial vascular stenosis. The myocardial ischemia assessment method provided by the present invention does not require the use of fluid mechanics. Since mechanical simulation is a simulation calculation, the assessment of myocardial ischemia obtained based on mechanical simulation is a simulation result. Compared with the assessment of myocardial ischemia obtained based on mechanical simulation, the results obtained by the quantification method of myocardial ischemia based on image processing of the non-invasive myocardial ischemia assessment system 01 provided by the present invention are more accurate and faster. The non-invasive myocardial ischemia assessment system 01 assesses the ischemic condition of actual myocardial perfusion through CTP-FFR, and has the advantages of rapid and accurate quantitative assessment of overall myocardial ischemia.

[0222] It should be noted that the myocardial ischemia assessment method and system, microcirculation disorder assessment method and system, microcirculation disorder calculation method and system, electronic device and computer storage medium provided by the present invention all have non-therapeutic purposes.

[0223] The myocardial ischemia assessment method and system, microcirculation disorder assessment method and system, and microcirculation disorder calculation method and system provided by the present invention are all based on the processing of medical images, that is, their direct objects are medical images, such as CCTA and CTP.

[0224] In some possible embodiments provided by the present invention, the myocardial blood flow acquisition module 014 of the target vascular perfusion region is used to acquire the quantitative myocardial blood flow of the target vascular perfusion region based on the slope of the rising period of the time-decay curve of the myocardial tissue in the myocardial perfusion region, the peak value and the target vascular area of ​​interest, and use the quantitative myocardial blood flow of the target vascular perfusion region as the myocardial blood flow MBF of the target vascular perfusion region in the case of stenosis. hyper-stenosis . This has been described in detail in the previous article and will not be repeated here.

[0225] In some possible embodiments provided by the present invention, the quantitative myocardial blood flow of the target blood vessel perfusion area includes at least one of the mean and median of the myocardial blood flow of the normal perfusion area of ​​the target blood vessel, and / or the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel includes at least one of the mean and median of the myocardial blood flow of the normal perfusion area of ​​the target blood vessel.

[0226] For example, the mean value of the myocardial blood flow in the normal perfusion area of ​​the target vessel is used as the myocardial blood flow MBF of the target vessel perfusion area under simulated normal conditions. hyper-normal The reasons have been explained in detail above and will not be elaborated here.

[0227] In some other possible embodiments, the median of the quantitative myocardial blood flow of the normal perfusion area of ​​the target vessel or other data statistics can be used as the myocardial blood flow MBF of the target vessel perfusion area under simulated normal conditions according to actual needs. hyper-normal, The present invention is not limited to this.

[0228] In some possible embodiments provided by the present invention, the myocardial ischemia assessment module 015 is used to estimate the myocardial blood flow MBF of the target vascular perfusion area under stenosis. hyper-stenosis MBF and target vascular perfusion area in simulated normal myocardial blood flow hyper-normal Get MBF hyper-stenosis and MBF hyper-normal The ratio of CTP-FFR is used as the ratio of blood flow in the diseased state and the healthy state:

[0229]

[0230] The CTP-FFR value is used to evaluate the proportion of myocardial ischemia caused by coronary artery stenosis. The proportion of myocardial ischemia caused by coronary artery stenosis is (1-CTP-FFR)*100%.

[0231] For example, a CTP-FFR result of 0.70 means that epicardial vascular stenosis under load will result in a blood flow reduction of (1-0.70)*100%, ie, 30%.

[0232] In some possible embodiments provided by the present invention, reference is made to Fig.14 The image processing module 012 includes an image segmentation module 0121, an image registration module 0122 and an image mapping module 0123.

[0233] The image segmentation module 0121 is used to segment the first image by using an image segmentation algorithm to obtain a coronary artery vascular tree image and a left ventricular myocardial structure image.

[0234] The image registration module 0122 is used to register the first image and the second image by an image registration method to obtain a registered image, wherein the registered image includes the coronary artery vascular tree and the left ventricular myocardial area.

[0235] The image mapping module 0123 is used to map the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree according to the registered image by an image mapping method to obtain a mapping image.

[0236] In some possible embodiments provided by the present invention, the image mapping module 0123 is used to map the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree by bifurcation principle mapping to obtain a mapping image.

[0237] In some possible embodiments provided by the present invention, the image mapping module 0123 is used to map the myocardial area of ​​the left ventricle to all coronary arteries with a lumen diameter ≥ 1 mm in the coronary artery tree by the principle of divide and conquer.

[0238] In some possible embodiments provided by the present invention, the image registration method includes at least one of: registration based on a traditional feature extraction method, registration based on a deep learning feature extraction method, and registration based on deep learning direct learning of geometric transformation. This has been described in detail above and will not be repeated here.

[0239] For example, in this embodiment, a registration method based on deep learning is used to register the first image and the second image, so that the first image and the second image are spatially aligned to obtain a registered image, and the registered image includes the coronary artery vascular tree and the left ventricular myocardial area. This has been described in detail above and will not be repeated here.

[0240] Thirdly, reference Fig.15 The present invention provides a method for evaluating microcirculation disorders, comprising:

[0241] S61: Obtain the proportion of myocardial ischemia caused by coronary artery stenosis CTP-FFR by the myocardial ischemia assessment method of any embodiment of the first aspect. CTP-FFR is the blood flow reserve fraction based on the CT myocardial perfusion image CTP under load, that is, the blood flow reserve fraction FFR directly obtained by image processing based on the CTP image.

[0242] S62: The proportion of myocardial ischemia caused by epicardial vascular stenosis is obtained according to the CT-FFR method for evaluating epicardial vascular stenosis. CT-FFR is the blood flow reserve fraction based on coronary CT angiography, that is, the blood flow reserve fraction FFR obtained based on CT images, through image processing, mechanical simulation, and pressure gradient calculation.

[0243] S63: Evaluate the proportion of microcirculatory disturbance based on the proportion of myocardial ischemia caused by coronary artery stenosis (CTP-FFR) and the proportion of myocardial ischemia caused by epicardial vascular stenosis (CT-FFR):

[0244] △CT-FFR=CT-FFR-CTP-FFR formula 2.

[0245] CT-FFR evaluates ischemia caused by epicardial vascular stenosis, while CTP-FFR can evaluate the actual myocardial perfusion ischemia.

[0246] For example, if the CTP-FFR result is 0.70 and the CT-FFR result is 0.80, it means that epicardial stenosis causes (1-0.80)*100%, or a 20% blood flow reduction, and microcirculatory disorder causes (0.80-0.70)*100%, or a 10% blood flow reduction.

[0247] Using the above technical solution, since CT-FFR evaluates ischemia caused by epicardial vascular stenosis, and CTP-FFR can evaluate the ischemia of actual myocardial perfusion, the numerical difference between CT-FFR and CTP-FFR is used to indicate the degree of ischemia caused by microcirculatory disorders. This is simple and efficient, and since the microcirculatory disorder evaluation method adopts a non-invasive approach, it is safer.

[0248] In some possible embodiments provided by the present invention, the CT-FFR method for evaluating epicardial vascular stenosis includes at least one of CT-QFR based on simplified fluid dynamics equations, FFRct based on computational fluid dynamics simulation, and CT-FFR based on machine learning.

[0249] CT-QFR is a method based on simplified fluid dynamics equations that uses CT images to estimate the geometry of blood vessels and hemodynamic parameters to calculate FFR. CT-QFR usually requires input of some assumptions, such as blood is a Newtonian fluid and flow is laminar.

[0250] FFRct uses computational fluid dynamics (CFD) simulation to assess blood flow dynamics. It takes into account more complex blood flow characteristics, such as non-Newtonian fluid behavior and turbulent flow.

[0251] CT-FFR, machine learning-based methods such as deep learning can automatically learn vascular anatomy and hemodynamic parameters from CT images to predict FFR. These methods can estimate FFR more accurately, especially in the presence of complex vascular lesions.

[0252] Fourthly, reference Fig.16 The present invention provides a microcirculation disorder assessment system 02, including a myocardial ischemia assessment module 015 and a microcirculation disorder assessment module 022.

[0253] The myocardial ischemia assessment module 015 is used to obtain the proportion of myocardial ischemia caused by coronary artery stenosis CTP-FFR through the myocardial ischemia assessment method as described in any embodiment of the first aspect.

[0254] The myocardial ischemia assessment module 015 is further used to obtain the proportion CT-FFR of myocardial ischemia caused by epicardial vascular stenosis according to the CT-FFR method for assessing epicardial vascular stenosis.

[0255] The microcirculation disorder assessment module 022 is used to assess the microcirculation disorder ratio ΔCT-FFR based on the ratio of myocardial ischemia caused by coronary artery stenosis CTP-FFR and the ratio of myocardial ischemia caused by epicardial vascular stenosis CT-FFR obtained by the myocardial ischemia assessment module:

[0256] △CT-FFR=CT-FFR-CTP-FFR formula 2.

[0257] By adopting the above technical scheme, CT-FFR and CTP-FFR are obtained through the joint action of the myocardial ischemia assessment module 015 and the microcirculation disorder assessment module 022. Since CT-FFR assesses ischemia caused by epicardial vascular stenosis, and CTP-FFR can assess the ischemia of actual myocardial perfusion, the numerical difference between CT-FFR and CTP-FFR indicates the degree of ischemia caused by microcirculation disorder, which is simple and efficient. In addition, since the microcirculation disorder assessment system 02 adopts a non-invasive method, it is safer.

[0258] In some possible embodiments provided by the present invention, the CT-FFR method for evaluating epicardial vascular stenosis includes at least one of CT-QFR based on simplified fluid dynamics equations, FFRct based on computational fluid dynamics simulation, and CT-FFR based on machine learning. The specific contents of the aforementioned CT-FFR method for evaluating epicardial vascular stenosis are as described above.

[0259] The Basic Research Group of the Chinese Society of Cardiology recommends the use of indicators such as the index of microvascular resistance (IMR) and coronary flow reserve (CFR) to assess coronary microcirculatory dysfunction in the "Chinese Expert Consensus on the Diagnosis and Treatment of Coronary Microvascular Disease". IMR can effectively reflect distal microcirculatory resistance, and CFR can reflect myocardial ischemia caused by both epicardial vascular and microcirculatory dysfunction. However, for patients with microcirculatory disorders combined with obstructive coronary artery disease, clinicians are unable to distinguish the effects of the two on myocardial ischemia based on existing indicators to develop corresponding treatment strategies.

[0260] In addition, it is not easy to obtain indicators such as coronary blood flow reserve CFR and microcirculation resistance index IMR clinically due to the reasons such as professional equipment and technical support are usually required, high technical equipment requirements, complexity and professionalism of operation, interference from the patient's physiological and pathological conditions, such as the patient's heart rate, blood pressure, electrolyte imbalance and other physiological conditions, and pathological conditions such as arrhythmia, myocardial infarction, and pericardial tamponade.

[0261] Therefore, the fifth aspect of the present invention provides a non-invasive assessment method for myocardial ischemia based on imaging, which realizes a method for quantitative assessment of microcirculatory resistance.

[0262] refer to Fig.17 Combined with Fig.18 The present invention provides a method for calculating microcirculatory obstacle resistance, comprising:

[0263] S8: Obtain the aortic pressure P of the coronary system through the systolic and diastolic blood pressures of the target subject 0 .

[0264] In some possible embodiments provided by the present invention, the aortic pressure P of the coronary system is obtained by the systolic and diastolic pressures of the target subject. 0 , including at least one of the following calculation methods: aortic pressure P 0 = diastolic pressure + 1 / 3 (systolic pressure - diastolic pressure) + 5 mmHg; aortic pressure P 0 = diastolic blood pressure + 0.412 (systolic blood pressure - diastolic blood pressure).

[0265] In some other possible embodiments provided by the present invention, the systolic and diastolic blood pressures of the target object may be used for other calculations.

[0266] In the present invention, since the systolic and diastolic blood pressure values ​​of the target object are specific, the calculated aortic pressure P 0 Be personalized.

[0267] S9: Obtain the venous pressure P of the coronary system 2 , the venous pressure P of the coronary system under load 2 It is 5mmHg.

[0268] In this embodiment, the venous pressure P of the coronary system under load 2 5 mmHg is a value obtained based on past experience.

[0269] S10: Acquire a second image, where the second image is a CT myocardial perfusion image CTP under load.

[0270] S11: Based on the second image, the myocardial blood flow MBF of the target vascular perfusion area under stenosis is obtained by the myocardial ischemia assessment method in any embodiment of the first aspect. hyper-stenosis , obtain the myocardial blood flow (MBF) of the target vascular perfusion area under simulated normal conditions hyper-normal .

[0271] That is, step S11 includes steps S4, S41 and S5 in the aforementioned myocardial ischemia assessment method of the first aspect. Specifically,

[0272] Execute step S4: according to the second image, obtain the time-attenuation curve of the myocardial tissue in the myocardial perfusion area, obtain the quantitative myocardial blood flow of the target vascular perfusion area based on the time-attenuation curve of the myocardial tissue, and use the quantitative myocardial blood flow of the target vascular perfusion area as the myocardial blood flow MBF of the target vascular perfusion area in the case of stenosis hyper-stenosis ,include:

[0273] Execute step S41: obtain the quantitative myocardial blood flow of the target vascular perfusion area based on the slope and peak value of the time-decay curve of the myocardial tissue in the myocardial perfusion area, and use the quantitative myocardial blood flow of the target vascular perfusion area as the myocardial blood flow MBF of the target vascular perfusion area in the case of stenosis hyper-stenosis .

[0274] S5: Acquire the quantitative myocardial blood flow of the normal perfusion area of ​​the target vessel, and use the quantitative myocardial blood flow of the normal perfusion area of ​​the target vessel as the myocardial blood flow MBF of the target vessel perfusion area under simulated normal conditions hyper-normal .

[0275] Continue to refer Fig.17 Combined with Fig.18 , execute step S12: according to the aortic pressure P of the coronary system 0 , venous pressure P of the coronary system 2 , Myocardial blood flow (MBF) in the target vascular perfusion area under simulated normal conditions hyper-normal Obtain the resistance R caused by microcirculation to blood flow under normal conditions.

[0276] The resistance to blood flow posed by the microcirculation under normal conditions is determined by a variety of factors, including the geometric characteristics of the blood vessels, such as vessel radius, length and branching pattern; the physical properties of the blood, such as viscosity and density; and the physiological properties of the vessel wall, such as elasticity and smooth muscle tone. The microcirculation is the smallest part of the cardiovascular system, including capillaries, arterioles and venules, which are essential for maintaining tissue perfusion and metabolism. Microcirculatory resistance is usually not measured directly, but is indirectly assessed by calculating the resistance of the entire cardiac circulation. This can be achieved by measuring aortic pressure and coronary venous pressure and calculating myocardial blood flow.

[0277] Execute step S13: according to the aortic pressure P of the coronary system 0 , the ratio of myocardial ischemia caused by epicardial vascular stenosis obtained by the microcirculatory disorder evaluation method in any embodiment of the third aspect, and the pressure P of the distal epicardial blood vessel 1 .

[0278] S14: According to the pressure P at the distal end of the epicardial vessels 1 , venous pressure P of the coronary system 2 , myocardial blood flow (MBF) in the target vascular perfusion area under stenosis hyper-stenosis , the resistance R caused by microcirculation to blood flow under normal conditions, the aortic pressure P of the coronary system 0 Obtain the resistance R caused by microcirculatory disorders to blood flow 2 .

[0279] For patients with microcirculatory disorders and obstructive coronary artery disease, clinicians do face a challenge: some existing indicators may not be able to fully distinguish the separate effects of coronary artery stenosis and microcirculatory disorders on myocardial ischemia. This is because myocardial ischemia may be due to coronary artery stenosis, i.e., macrovascular disease, or microcirculatory dysfunction, or a combination of both.

[0280] Traditional assessment methods, such as coronary angiography, focus mainly on the degree of stenosis of large vessels. However, even in the absence of significant stenosis of large vessels, microcirculatory disturbances may lead to myocardial ischemia. Microcirculatory disturbances may be caused by a variety of factors, including endothelial dysfunction, inflammation, platelet activation, vasoconstriction, and oxidative stress.

[0281] The method for calculating microcirculatory obstruction resistance provided by the present invention is a non-invasive assessment method for myocardial ischemia based on imaging, and realizes quantitative assessment of microcirculatory obstruction resistance.

[0282] The microcirculatory resistance index (IMR) is considered to be the reference standard for evaluating microcirculatory resistance and is defined as the distal coronary artery pressure (P dist ) and distal blood flow (Q dist ) ratio.

[0283] refer to Fig.18 The calculation method of microcirculatory resistance provided by the present invention takes into account the myocardial blood flow MBF of the target vascular perfusion area under stenosis. hyper-stenosis The resistance to blood flow from the epicardium R 1 , the resistance to blood flow caused by microcirculatory disorders R 2 And the influence of three kinds of resistance R caused by microcirculation on blood flow under normal conditions.

[0284] Among them, aortic pressure P 0 The epicardium resists blood flow. 1 Decreased pressure at the distal epicardial vessels 1 .

[0285] Resistance to blood flow caused by microcirculatory disturbances 2 As well as the resistance R of microcirculation to blood flow under normal conditions, the vascular pressure will be determined by the pressure P at the distal end of the epicardial blood vessels. 1 Reduced to venous pressure P 2 According to the pressure difference between the two and the myocardial blood flow (MBF) of the target vascular perfusion area under stenosis hyper-stenosis The resistance R caused by microcirculatory disorders to blood flow can be calculated 2 And the sum of the resistance R caused by the microcirculation to blood flow under normal conditions.

[0286] The resistance R caused by microcirculation to blood flow is objective and can be measured by the aortic pressure P 0 , venous pressure P 2 MBF of the target vascular perfusion area under simulated normal conditions hyper-normal Obtained by calculation.

[0287] Therefore, the resistance R caused by microcirculatory disturbance to blood flow 2 The resistance R caused by microcirculatory disturbance to blood flow can be calculated by the sum of the above resistances ( 2 The resistance R caused by microcirculation to blood flow in normal state is obtained by comparing the resistance R caused by microcirculation to blood flow in normal state, that is, the resistance R caused by microcirculation disorder to blood flow 2It is equal to the difference between the sum of the aforementioned resistances and the resistance R caused by the microcirculation to blood flow under normal conditions.

[0288] The microcirculatory disorder resistance calculation method provided by the present invention not only takes into account the effect of epicardial vascular stenosis on blood flow, but also takes into account the inherent resistance of the microcirculation itself. It can more accurately evaluate the effect of microcirculatory disorders on myocardial perfusion, thereby providing a more comprehensive myocardial ischemia assessment.

[0289] In some possible embodiments provided by the present invention, reference is made to Fig.17 and Fig.18 ,like Fig.17 Step S12 shown: Based on the aortic pressure P of the coronary system 0 , venous pressure P of the coronary system 2 , Myocardial blood flow (MBF) in the target vascular perfusion area under simulated normal conditions hyper-normal The resistance R caused by microcirculation to blood flow under normal conditions is obtained by calculation:

[0290]

[0291] The resistance R caused by microcirculation to blood flow is objective and can be measured by the aortic pressure P 0 , venous pressure P 2 MBF of the target vascular perfusion area under simulated normal conditions hyper-normal Obtained by calculation.

[0292] In some possible embodiments provided by the present invention, reference is made to Fig.17 and Fig.18 ,like Fig.17 Step S13 shown: Based on the aortic pressure P of the coronary system 0 , the ratio of myocardial ischemia caused by epicardial vascular stenosis obtained by the microcirculatory disorder evaluation method in any embodiment of the third aspect, and the pressure P of the distal epicardial blood vessel 1 , calculated as:

[0293] P 1 =P 0 *CT-FFR formula 4.

[0294] In some possible embodiments provided by the present invention, reference is made to Fig.17 and Fig.18 ,like Fig.17 Step S14 is shown: according to the pressure P at the distal end of the epicardial blood vessel 1 , venous pressure P of the coronary system 2 , myocardial blood flow (MBF) in the target vascular perfusion area under stenosis hyper-stenosis, the resistance R caused by microcirculation to blood flow under normal conditions, the aortic pressure P of the coronary system 0 Obtain the resistance R caused by microcirculatory disorders to blood flow 2 , calculated as:

[0295]

[0296] As mentioned above, the resistance to blood flow caused by microcirculatory disturbances R 2 As well as the resistance R of microcirculation to blood flow under normal conditions, the vascular pressure will be determined by the pressure P at the distal end of the epicardial blood vessels. 1 Reduced to venous pressure P 2 According to the pressure difference between the two and the myocardial blood flow (MBF) of the target vascular perfusion area under stenosis hyper-stenosis The resistance R caused by microcirculatory disorders to blood flow can be calculated 2 And the sum of the resistance R caused by the microcirculation to blood flow under normal conditions.

[0297] The resistance to blood flow caused by microcirculatory disturbances is 2 The resistance R caused by microcirculatory disturbance to blood flow can be calculated by the sum of the above resistances ( 2 The resistance R caused by microcirculation to blood flow in normal state is obtained by comparing the resistance R caused by microcirculation to blood flow in normal state, that is, the resistance R caused by microcirculation disorder to blood flow 2 It is equal to the difference between the sum of the aforementioned resistances and the resistance R caused by the microcirculation to blood flow under normal conditions.

[0298] Sixth, reference Fig.19 The present invention provides a microcirculation barrier resistance calculation system 03, including a data acquisition module 031, an image acquisition and analysis module 032 and a data processing module 033.

[0299] The data acquisition module 031 is used to obtain the aortic pressure P of the coronary system through the systolic pressure and diastolic pressure of the target object. 0 ; Obtain the venous pressure P of the coronary system 2 , the venous pressure P of the coronary system under load 2 It is 5mmHg.

[0300] The image acquisition and analysis module 032 is used to acquire a second image, which is a CT myocardial perfusion image CTP under load; based on the second image, the myocardial blood flow MBF of the target vascular perfusion area under stenosis is acquired by the myocardial ischemia assessment method in any embodiment of the first aspect. hyper-stenosis , obtain the myocardial blood flow (MBF) of the target vascular perfusion area under simulated normal conditions hyper-normal .

[0301] The data processing module 033 is used to calculate the aortic pressure P of the coronary system. 0 , venous pressure P of the coronary system 2 , Myocardial blood flow (MBF) in the target vascular perfusion area under simulated normal conditions hyper-normal Obtain the resistance R of microcirculation to blood flow under normal conditions; used to calculate the aortic pressure P of the coronary system 0 , the ratio of myocardial ischemia caused by epicardial vascular stenosis obtained by the microcirculatory disorder evaluation method in any embodiment of the third aspect, and the pressure P of the distal epicardial blood vessel 1 ; used to calculate the pressure P at the distal end of the epicardial vessels 1 , venous pressure P of the coronary system 2 , myocardial blood flow (MBF) in the target vascular perfusion area under stenosis hyper-stenosis , the resistance R caused by microcirculation to blood flow under normal conditions, the aortic pressure P of the coronary system 0 Obtain the resistance R caused by microcirculatory disorders to blood flow 2 .

[0302] By adopting the above technical solution, the microcirculatory obstacle resistance calculation system 03 takes into account the resistance R caused by the microcirculation of the coronary artery to the blood flow under normal conditions, and realizes the resistance R caused by the microcirculatory obstacle to the blood flow. 2 This means that the evaluation not only takes into account the resistance to blood flow R 1 , and also considers the resistance R of the microcirculation of the coronary artery to blood flow under normal conditions. The system 03 can more accurately evaluate the impact of microcirculatory disorders on myocardial perfusion, thereby providing a more comprehensive assessment of myocardial ischemia.

[0303] In some possible embodiments provided by the present invention, according to the aortic pressure P of the coronary system 0 , venous pressure P of the coronary system 2 , Myocardial blood flow (MBF) in the target vascular perfusion area under simulated normal conditions hyper-normal The resistance R caused by microcirculation to blood flow under normal conditions is obtained by calculation:

[0304]

[0305] In some possible embodiments provided by the present invention, according to the aortic pressure P of the coronary system 0 , the ratio of myocardial ischemia caused by epicardial vascular stenosis obtained by the microcirculatory disorder evaluation method in any embodiment of the third aspect, and the pressure P of the distal epicardial blood vessel 1 , calculated as:

[0306] P1 =P 0 *CT-FFR formula 4.

[0307] In some possible embodiments provided by the present invention, according to the pressure P at the distal end of the epicardial blood vessel 1 , venous pressure P of the coronary system 2 , myocardial blood flow (MBF) in the target vascular perfusion area under stenosis hyper-stenosis , the resistance R caused by microcirculation to blood flow under normal conditions, the aortic pressure P of the coronary system 0 Obtain the resistance R caused by microcirculatory disorders to blood flow 2 , calculated as:

[0308]

[0309] In some possible embodiments provided by the present invention, the aortic pressure P of the coronary system is obtained by the systolic and diastolic pressures of the target subject. 0 , including at least one of the following calculation methods: aortic pressure P 0 = diastolic pressure + 1 / 3 (systolic pressure - diastolic pressure) + 5 mmHg; aortic pressure P 0 = diastolic blood pressure + 0.412 (systolic blood pressure - diastolic blood pressure).

[0310] Seventh, reference Fig. 20 The present invention provides an electronic device 2, comprising a memory 201, a processor 202, and a computer program stored in the memory 201 and executable on the processor 202. When the processor 202 executes the computer program, the myocardial ischemia assessment method in any embodiment of the first aspect or the microcirculation disorder assessment method in any embodiment of the third aspect or the microcirculation disorder resistance calculation method in any embodiment of the fifth aspect is implemented. The memory 201 may include, for example, a system memory, a fixed non-volatile storage medium, etc. The system memory may store, for example, an operating system, an application program, a boot loader, and other programs.

[0311] In this embodiment, the electronic device realizes rapid, accurate and reliable quantitative assessment of the overall myocardial ischemia through the myocardial ischemia assessment method provided by the first aspect of the present invention; through the microcirculation disorder assessment method provided by the third aspect, the numerical difference between the ischemia CT-FFR caused by epicardial vascular stenosis and the ischemia CTP-FFR of the actual myocardial perfusion ischemia indicates the degree of ischemia caused by microcirculation disorders, which is simple and efficient, and because the microcirculation disorder assessment method adopts a non-invasive method, it is safer; through the calculation method of microcirculation disorder resistance provided by the fifth aspect, not only the effect of epicardial vascular stenosis on blood flow is taken into account, but also the inherent resistance of the microcirculation itself, so that the effect of microcirculation disorders on myocardial perfusion can be more accurately assessed, thereby providing a more comprehensive myocardial ischemia assessment.

[0312] In an eighth aspect, an embodiment of the present invention further provides a computer-readable storage medium, the computer-readable storage medium storing a computer program, which, when executed by a processor, implements the myocardial ischemia assessment method in any embodiment of the first aspect, or implements the microcirculation disorder assessment method in any embodiment of the third aspect, or implements the microcirculation disorder resistance calculation method in any embodiment of the fifth aspect.

[0313] By adopting the above technical scheme, the computer-readable storage medium realizes rapid, accurate and reliable quantitative evaluation of the overall myocardial ischemia through the myocardial ischemia evaluation method provided by the first aspect of the present invention; through the microcirculation disorder evaluation method provided by the third aspect, the numerical difference between the ischemia CT-FFR caused by epicardial vascular stenosis and the ischemia CTP-FFR of the actual myocardial perfusion is used to indicate the degree of ischemia caused by microcirculation disorder, which is simple and efficient, and because the microcirculation disorder evaluation method adopts a non-invasive method, it is safer; through the calculation method of microcirculation disorder resistance provided by the fifth aspect, not only the effect of epicardial vascular stenosis on blood flow is taken into account, but also the inherent resistance of the microcirculation itself, so that the effect of microcirculation disorder on myocardial perfusion can be more accurately evaluated, thereby providing a more comprehensive myocardial ischemia evaluation.

[0314] Those skilled in the art will appreciate that embodiments of the present invention may be provided as methods, systems, or computer program products. Therefore, the present invention may take the form of a complete hardware embodiment, a complete software embodiment, or an embodiment combining software and hardware. Moreover, the present invention may take the form of a computer program product implemented on one or more computer-usable non-transient storage media (including but not limited to disk storage, CD-ROM, optical storage, etc.) containing computer-usable program code.

[0315] The present invention is described with reference to flowcharts and / or block diagrams of methods, devices (systems), and computer program products according to embodiments of the present invention. It should be understood that each process and / or block in the flowchart and / or block diagram, as well as the combination of processes and / or blocks in the flowchart and / or block diagram, can be implemented by computer program instructions. These computer program instructions can be provided to a processor of a general-purpose computer, a special-purpose computer, an embedded processor, or other programmable data processing device to generate a machine, so that the instructions executed by the processor of the computer or other programmable data processing device generate instructions for implementing the processes in the flowchart and / or block diagram. Figure 1 A process or multiple processes and / or boxes Figure 1 A device that provides the functions specified in a block or multiple blocks.

[0316] These computer program instructions may also be stored in a computer-readable memory capable of directing a computer or other programmable data processing device to operate in a specific manner, so that the instructions stored in the computer-readable memory produce an article of manufacture comprising an instruction device, which implements the process Figure 1 A process or multiple processes and / or boxes Figure 1 A function specified in one or more boxes.

[0317] These computer program instructions can also be loaded onto a computer or other programmable data processing device so that a series of operating steps are executed on the computer or other programmable device to produce a computer-implemented process, thereby providing instructions for implementing the process in the computer or other programmable device. Figure 1 A process or multiple processes and / or boxes Figure 1 The steps for the functions specified in one or more boxes.

[0318] Although the present invention has been illustrated and described with reference to certain preferred embodiments of the present invention, it should be understood by those skilled in the art that the above is a further detailed description of the present invention in conjunction with specific embodiments, and it cannot be determined that the specific implementation of the present invention is limited to these descriptions. Those skilled in the art may make various changes in form and details, including making several simple deductions or substitutions, without departing from the spirit and scope of the present invention.

Claims

1. A method for evaluating myocardial ischemia, characterized in that: include: Acquire a first image and a second image, wherein the first image is a coronary CT angiography image CCTA, and the second image is a CT myocardial perfusion image CTP under load; According to the first image and the second image, mapping the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree by an image processing method to obtain a mapping image; calibrating a target vascular perfusion area in the mapping image; A time-attenuation curve of myocardial tissue in the myocardial perfusion area is obtained according to the second image, and a quantitative myocardial blood flow in the target vascular perfusion area is obtained based on the time-attenuation curve of the myocardial tissue and the target vascular perfusion area, and the quantitative myocardial blood flow in the target vascular perfusion area is used as the myocardial blood flow MBF of the target vascular perfusion area in the case of stenosis. hyper-stenosis ; Acquire the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel, and use the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel as the myocardial blood flow MBF of the target blood vessel perfusion area under simulated normal conditions. hyper-normal ; MBF according to the myocardial blood flow in the target vascular perfusion area under stenosis hyper-stenosis and the myocardial blood flow (MBF) of the target vascular perfusion area under simulated normal conditions hyper-normal , CTP-FFR is used to evaluate the proportion of myocardial ischemia caused by coronary artery stenosis.

2. The myocardial ischemia assessment method according to claim 1, characterized in that: The time-attenuation curve of the myocardial tissue in the myocardial perfusion area is obtained according to the second image, the quantitative myocardial blood flow of the target vascular perfusion area is obtained based on the time-attenuation curve of the myocardial tissue and the target vascular perfusion area, and the quantitative myocardial blood flow of the target vascular perfusion area is used as the myocardial blood flow MBF of the target vascular perfusion area in the case of stenosis. hyper-stenosis ,include: The quantitative myocardial blood flow of the target vascular perfusion area is obtained based on the rising slope and peak value of the time-decay curve of the myocardial tissue in the myocardial perfusion area and the target vascular area of ​​interest, and the quantitative myocardial blood flow of the target vascular perfusion area is used as the myocardial blood flow MBF of the target vascular perfusion area in the case of stenosis. hyper-stenosis .

3. The myocardial ischemia assessment method according to claim 1, wherein: The quantitative myocardial blood flow of the target blood vessel perfusion area includes at least one of the mean and median of the myocardial blood flow of the normal perfusion area of ​​the target blood vessel, and / or the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel includes at least one of the mean and median of the myocardial blood flow of the normal perfusion area of ​​the target blood vessel.

4. The myocardial ischemia assessment method according to claim 1, wherein: MBF according to the myocardial blood flow in the target vascular perfusion area under stenosis hyper-stenosis and the myocardial blood flow (MBF) of the target vascular perfusion area under simulated normal conditions hyper-normal Get MBF hyper-stenosis and MBF hyper-normal The ratio of CTP-FFR is used as the ratio of blood flow in the diseased state and the healthy state: The value of CTP-FFR is used to evaluate the proportion of myocardial ischemia caused by coronary artery stenosis, and the proportion of myocardial ischemia caused by coronary artery stenosis is (1-CTP-FFR)*100%.

5. The myocardial ischemia assessment method according to claim 1, wherein: Mapping the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree by an image processing method according to the first image and the second image to obtain a mapping image includes: Segmenting the first image using a first image segmentation algorithm to obtain a coronary artery vascular tree image, and segmenting the second image using a second image segmentation algorithm to obtain a left ventricular myocardial structure image; Registering the first image and the second image by an image registration method to obtain a registered image, wherein the registered image is the registered first image; According to the registered image and the second image, the left ventricular myocardial structure region of the left ventricular myocardial structure image is mapped to each blood vessel of the coronary artery vascular tree in the coronary artery vascular tree image by an image mapping method to obtain a mapping image.

6. The myocardial ischemia assessment method according to claim 5, characterized in that: The step of mapping the left ventricular myocardial structure region of the left ventricular myocardial structure image to each blood vessel of the coronary artery vascular tree in the coronary artery vascular tree image by an image mapping method according to the registered image and the second image to obtain a mapping image includes: Mapping the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree by bifurcation principle mapping to obtain a mapping image; preferably, further comprising: The myocardial area of ​​the left ventricle is mapped to all coronary arteries with a lumen diameter of ≥1 mm in the coronary artery tree by the principle of divide and conquer.

7. A myocardial ischemia assessment system, characterized in that: include: An image acquisition module, used to acquire a first image and a second image, wherein the first image is a coronary CT angiography image CCTA, and the second image is a CT myocardial perfusion image CTP under load; An image processing module, configured to map the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree by an image processing method according to the first image and the second image, so as to obtain a mapping image; An image calibration module, used for calibrating a target blood vessel perfusion area in the mapping image; a myocardial blood flow acquisition module for the target vascular perfusion region, for acquiring a time-attenuation curve of the myocardial tissue in the myocardial perfusion region according to the second image, acquiring a quantitative myocardial blood flow in the target vascular perfusion region based on the time-attenuation curve of the myocardial tissue and the target vascular perfusion region, and using the quantitative myocardial blood flow in the target vascular perfusion region as the myocardial blood flow MBF of the target vascular perfusion region in the case of stenosis hyper-stenosis ; used to obtain the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel, and use the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel as the myocardial blood flow MBF of the target blood vessel perfusion area under simulated normal conditions hyper-normal ; Myocardial ischemia assessment module, used to evaluate the myocardial blood flow (MBF) of the target vascular perfusion area under stenosis hyper-stenosis and the myocardial blood flow (MBF) of the target vascular perfusion area under simulated normal conditions hyper-normal , CTP-FFR is used to evaluate the proportion of myocardial ischemia caused by coronary artery stenosis.

8. The myocardial ischemia assessment system according to claim 7, characterized in that: The myocardial blood flow acquisition module of the target vascular perfusion area is used to obtain the quantitative myocardial blood flow of the target vascular perfusion area based on the rising slope and peak value of the time-decay curve of the myocardial tissue in the myocardial perfusion area and the target vascular area of ​​interest, and use the quantitative myocardial blood flow of the target vascular perfusion area as the myocardial blood flow MBF of the target vascular perfusion area in the case of stenosis. hyper-stenosis .

9. The myocardial ischemia assessment system according to claim 7, wherein: The quantitative myocardial blood flow of the target blood vessel perfusion area includes at least one of the mean and median of the myocardial blood flow of the normal perfusion area of ​​the target blood vessel, and / or the quantitative myocardial blood flow of the normal perfusion area of ​​the target blood vessel includes at least one of the mean and median of the myocardial blood flow of the normal perfusion area of ​​the target blood vessel.

10. The myocardial ischemia assessment system according to claim 7, characterized in that: The myocardial ischemia assessment module is used to estimate the myocardial blood flow (MBF) of the target vascular perfusion area under stenosis. hyper-stenosis and the myocardial blood flow (MBF) of the target vascular perfusion area under simulated normal conditions hyper-normal Get MBF hyper-stenosis and MBF hyper-normal The ratio of CTP-FFR is used as the ratio of blood flow in the diseased state and the healthy state: The value of CTP-FFR is used to evaluate the proportion of myocardial ischemia caused by coronary artery stenosis, and the proportion of myocardial ischemia caused by coronary artery stenosis is (1-CTP-FFR)*100%.

11. The myocardial ischemia assessment system according to claim 7, characterized in that: The image processing module comprises: An image segmentation module, configured to segment the first image using a first image segmentation algorithm to obtain a coronary artery vascular tree image, and segment the second image using a second image segmentation algorithm to obtain a left ventricular myocardial structure image; An image registration module, used for registering the first image and the second image by an image registration method to obtain a registered image, wherein the registered image is the registered first image; An image mapping module is used to map the left ventricular myocardial structure area of ​​the left ventricular myocardial structure image to each blood vessel of the coronary artery vascular tree in the coronary artery vascular tree image through an image mapping method according to the registered image and the second image, so as to obtain a mapping image.

12. The myocardial ischemia assessment system according to claim 11, characterized in that: The image mapping module is used to map the left ventricular myocardial area to each blood vessel in the coronary artery vascular tree through bifurcation principle mapping to obtain a mapping image; preferably, it further includes: the image mapping module is used to map the left ventricular myocardial area to all coronary arteries with a lumen diameter ≥ 1 mm in the coronary artery vascular tree through the principle of divide and conquer.

13. A method for evaluating microcirculatory disorders, characterized in that: include: Obtaining the proportion of myocardial ischemia caused by coronary artery stenosis CTP-FFR by the myocardial ischemia assessment method according to any one of claims 1 to 6; The proportion of myocardial ischemia caused by epicardial vascular stenosis was obtained according to the CT-FFR method for evaluating epicardial vascular stenosis; The proportion of myocardial ischemia caused by coronary artery stenosis CTP-FFR and the proportion of myocardial ischemia caused by epicardial vascular stenosis CT-FFR were used to evaluate the proportion of microcirculatory disorders △CT-FFR: △CT-FFR=CT-FFR-CTP-FFR formula 2.

14. A microcirculatory disorder assessment system, characterized in that: include: A myocardial ischemia assessment module, used to obtain the ratio of myocardial ischemia caused by coronary artery stenosis CTP-FFR by using the myocardial ischemia assessment method according to any one of claims 1 to 6; The myocardial ischemia assessment module is also used to obtain a proportion CT-FFR of myocardial ischemia caused by epicardial vascular stenosis according to a CT-FFR method for assessing epicardial vascular stenosis; The microcirculation disorder assessment module is used to assess the microcirculation disorder ratio ΔCT-FFR based on the ratio of myocardial ischemia caused by coronary artery stenosis CTP-FFR and the ratio of myocardial ischemia caused by epicardial vascular stenosis CT-FFR obtained by the myocardial ischemia assessment module: △CT-FFR=CT-FFR-CTP-FFR formula 2.

15. A method for calculating microcirculatory resistance, characterized in that: include: The aortic pressure P0 of the coronary system is obtained by the systolic and diastolic blood pressures of the target subject; Acquiring the venous pressure P2 of the coronary system, wherein the venous pressure P2 of the coronary system under load is 5 mmHg; Acquiring a second image, where the second image is a CT myocardial perfusion image CTP under a load state; According to the second image, the myocardial blood flow MBF of the target vascular perfusion area under stenosis is obtained by the myocardial ischemia assessment method according to any one of claims 1 to 6. hyper-stenosis , obtain the myocardial blood flow (MBF) of the target vascular perfusion area under simulated normal conditions hyper-normal ; According to the aortic pressure P0 of the coronary system, the venous pressure P2 of the coronary system, and the myocardial blood flow MBF of the target vascular perfusion area under simulated normal conditions hyper-normal Obtain the resistance R of microcirculation to blood flow under normal conditions; Obtain the pressure P1 of the distal end of epicardial blood according to the aorta pressure P0 of the coronary system and the proportion CT-FFR of myocardial ischemia caused by epicardial vascular stenosis obtained by the microcirculatory disorder evaluation method according to claim 13; According to the pressure P1 at the distal end of the epicardial vessel, the venous pressure P2 of the coronary system, and the myocardial blood flow MBF of the target vascular perfusion area under stenosis hyper-stenosis , the resistance R caused by microcirculation to blood flow under normal conditions, and the aortic pressure P0 of the coronary system to obtain the resistance R2 caused by microcirculation disorders to blood flow.

16. The method for calculating microcirculatory resistance according to claim 15, characterized in that: The aortic pressure P0 of the coronary system, the venous pressure P2 of the coronary system, and the myocardial blood flow MBF of the target vascular perfusion area under simulated normal conditions are described. hyper-normal The resistance R caused by microcirculation to blood flow under normal conditions is obtained by calculation: Alternatively, the pressure P1 at the distal end of the epicardial blood is obtained according to the aortic pressure P0 of the coronary system and the proportion CT-FFR of myocardial ischemia caused by epicardial vascular stenosis obtained by the microcirculatory disorder evaluation method according to claim 13, and the calculation method is: P1=P0*CT-FFR Formula 4.

17. The method for calculating microcirculatory barrier resistance according to claim 16, characterized in that: According to the pressure P1 at the distal end of the epicardial vessel, the venous pressure P2 of the coronary system, and the myocardial blood flow MBF of the target vascular perfusion area under stenosis hyper-stenosis , the resistance R caused by microcirculation to blood flow in the normal state, the aorta pressure P0 of the coronary system, and the resistance R2 caused by microcirculation disorder to blood flow are obtained, and the calculation method is:

18. The method for calculating microcirculatory barrier resistance according to claim 15, characterized in that: The method of obtaining the aortic pressure P0 of the coronary system by using the systolic and diastolic pressures of the target subject includes at least one of the following calculation methods: Aortic pressure P0 = diastolic pressure + 1 / 3 (systolic pressure - diastolic pressure) + 5 mmHg; Aortic pressure P0 = diastolic pressure + 0.412 (systolic pressure - diastolic pressure).

19. A system for calculating microcirculatory resistance, characterized in that: include: A data acquisition module is used to acquire the aortic pressure P0 of the coronary system through the systolic pressure and diastolic pressure of the target object; and acquire the venous pressure P2 of the coronary system, wherein the venous pressure P2 of the coronary system under load state is 5 mmHg; An image acquisition and analysis module is used to acquire a second image, wherein the second image is a CT myocardial perfusion image CTP under load; based on the second image, the myocardial blood flow MBF of the target vascular perfusion area under stenosis is acquired by the myocardial ischemia assessment method according to any one of claims 1 to 6. hyper-stenosis , obtain the myocardial blood flow (MBF) of the target vascular perfusion area under simulated normal conditions hyper-normal; The data processing module is used to calculate the myocardial blood flow MBF of the target vascular perfusion area under the simulated normal condition according to the aortic pressure P0 of the coronary system, the venous pressure P2 of the coronary system, and the hyper-normal Obtain the resistance R of microcirculation to blood flow under normal conditions; Used to obtain the pressure P1 of the distal end of epicardial blood according to the aortic pressure P0 of the coronary system and the proportion CT-FFR of myocardial ischemia caused by epicardial vascular stenosis obtained by the microcirculatory disorder evaluation method according to claim 13; For calculating the myocardial blood flow MBF according to the pressure P1 at the distal end of the epicardial blood vessel, the venous pressure P2 of the coronary system, and the target blood vessel perfusion area in the case of stenosis hyper-stenosis , the resistance R caused by microcirculation to blood flow under normal conditions, and the aortic pressure P0 of the coronary system to obtain the resistance R2 caused by microcirculation disorders to blood flow.

20. The microcirculatory barrier resistance calculation system according to claim 19, characterized in that: The data processing module is used to calculate the myocardial blood flow MBF of the target vascular perfusion area under simulated normal conditions according to the aortic pressure P0 of the coronary system, the venous pressure P2 of the coronary system, and the hyper-normal The resistance R caused by microcirculation to blood flow under normal conditions is obtained by calculation: Alternatively, the data processing module is used to obtain the pressure P1 at the distal end of the epicardial blood according to the aortic pressure P0 of the coronary system and the proportion CT-FFR of myocardial ischemia caused by epicardial vascular stenosis obtained by the microcirculatory disorder assessment method according to claim 17 or 18, and the calculation method is: P1=P0*CT-FFR Formula 4.

21. The microcirculatory barrier resistance calculation system according to claim 19, characterized in that: The data processing module is used to calculate the myocardial blood flow MBF of the target vascular perfusion area under stenosis according to the pressure P1 at the distal end of the epicardial blood vessel, the venous pressure P2 of the coronary system, and the hyper-stenosis , the resistance R caused by microcirculation to blood flow in the normal state, the aorta pressure P0 of the coronary system, and the resistance R2 caused by microcirculation disorder to blood flow are obtained, and the calculation method is:

22. The microcirculatory barrier resistance calculation system according to claim 19, characterized in that: The data acquisition module is used to obtain the aortic pressure P0 of the coronary system through the systolic pressure and diastolic pressure of the target object, including at least one of the following calculation methods: Aortic pressure P0 = diastolic pressure + 1 / 3 (systolic pressure - diastolic pressure) + 5 mmHg; Aortic pressure P0 = diastolic pressure + 0.412 (systolic pressure - diastolic pressure).

Citation Information

Patent Citations

  • Method and device for determining coronary artery microcirculation resistance

    CN109770930A

  • Method and system for quickly calculating fractional flow reserve based on simplified coronary zero-dimensional model and stenosis resistance prediction model

    CN113128139A

  • Coronary artery microcirculation detection and coronary artery analysis system

    CN113487535A

  • Coronary artery microcirculation resistance index calculation method and device based on CT image

    CN115869003A

  • Coronary artery fractional flow reserve prediction method and device based on cross-modal data

    CN117036530A